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 Human diseases caused by missing or dysfunctional protein ion channels, known 
as channelopathies, affect several organs and systems of the body including that of the 
heart, lungs, kidneys, and nervous system. Channelopathies can result in devastating 
and potentially life-threatening diseases. To date, more than 30 human channelopathies 
are incurable. Although significant advances have been made in both gene therapy and 
protein replacement therapies, there is still a major need for new treatment strategies. 
We questioned whether an imperfect small molecule mimic of a missing protein ion 
channel could be sufficient to restore physiology in protein-deficient systems.   
 Small molecules possess many qualities as potential therapeutics including that 
they are orally bio-available, cell permeable, and minimally immunogenic. Specifically for 
small molecule inhibitors, their primary mechanism of action is to bind to and block over-
active proteins. However, in the case of unexpressed or degraded proteins where no 
target is available, this approach is futile. We hypothesized that through functionally 
interfacing with inherent networks of protein ion pumps and transporters, an imperfect 
small molecule ion channel could be enough to rescue physiology.  
 Amphotericin B (AmB) is a prime example of an ion channel forming small 
molecule. Clinically for more than 60 years, medical providers have utilized AmB to treat 
patients suffering from invasive, systemic fungal infections. Previously, AmB’s mode of 
cell killing was thought to be through ion channel formation. However, The Burke Group 
at The University of Illinois at Urbana-Champaign showed that AmB kills yeast through 
sterol extraction. Moreover, we found that AmB only caused cell death when the ratio of 
AmB exceeded that of sterols; therefore, pre-complexation of AmB with sterols serves as 
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a strategy to ameliorate toxicity. Alternatively, to harness AmB’s ion channel forming 
activity, we employed this small molecule at low concentrations. Further characterization 
showed that AmB small molecule ion channels are unselective, wherein they conduct 
potassium (K+), sodium (Na+), chloride (Cl-), and bicarbonate (HCO3-) ions. 
 We employed Saccharomyces cerevisiae (S.cerevisiae) as an outstanding model 
organism because this unicellular eukaryote is genetically tractable, well-annotated, and 
amenable to genetic deletion. Furthermore, yeast have been widely utilized to elucidate 
several, fundamental biological processes including cell cycle regulation, telomere 
maintenance, and vesicle trafficking, and to characterize the pathophysiology of human 
disease. 
 Yeast express two primary K+ transporters, Trk1 and Trk2 that are localized to the 
plasma membrane. Proton (H+)-ATPases Pma1 and V-ATPase utilize the energy from 
ATP hydrolysis to drive H+ out of cells or into vacuoles respectively, thereby producing 
favorable electrochemical gradients. These gradients promote K+ flow through Trk1 and 
Trk2 passive transporters into cells, to achieve cytosolic concentrations around 200-300 
mM and cation storage into vacuoles. For cellular physiology, K+ is crucial for retaining 
intracellular pH, sustaining plasma membrane potential, and promoting enzyme activity. 
Deficiencies of these integral K+ transporters result in a loss of cell growth under standard 
laboratory conditions (10-15 mM K+).  
 We found that an imperfect small molecule mimic of a missing protein ion channel, 
a.k.a. molecular prosthetic is sufficient to restore physiology in a protein-deficient model 
organism. We demonstrated that AmB both vigorously and sustainably restored 
physiology in K+ transporter deficient yeast (trk1Δtrk2Δ). Furthermore, we showed that 
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AmB mediated rescue is ion channel dependent. Contributing to the lab’s molecular 
prostheses program, this thesis work has made four major contributions. 
 First, we predicted that small molecule mediated rescue is generalizable. Initially, 
we reconfirmed literature reports and demonstrated that Nystatin A1, Candicidin, and 
Mepartricin permeabilize yeast. Then to test our prediction, we employed two assays: the 
disc diffusion and micro-broth dilution assay. We observed no rescue of growth with a 
Natamycin control (does not form ion channels). In contrast, we observed restored cell 
growth for Nystatin A1 (optimal at 1 μM), Candicidin (8 nM), and Mepartricin (8 nM). These 
findings suggest the versatility of trk1Δtrk2Δ homeostatic mechanisms to functionally 
interface with different imperfect small molecule mimics, and thereby rescue physiology. 
 Second, we elucidated a mechanism by which imperfect small molecule ion 
channels rescue physiology in yeast. We hypothesized that small molecule mimics 
harness favorable electrochemical gradients to drive K+ into cells and back to 
physiological levels, thereby restoring cell growth in trk1Δtrk2Δ yeast. We have obtained 
evidence in support of each of these steps. Consistent with prior reports, trk1Δtrk2Δ yeast 
are hyperpolarized compared to that of WT. These gradients drive K+ into cells as 
demonstrated by radioactive rubidium (86Rb+, surrogate tracer for K+) influx assays. Next, 
we showed that through working together with the cell’s endogenous network of protein 
ion pumps, small molecule ion channels significantly restored total cellular K+ levels in 
trk1Δtrk2Δ back to that found in WT, in both a dose- and time-dependent manner. In 
contrast, Natamycin did not restore total cellular K+ content nor cell growth. Furthermore, 
chemical inhibition of H+-ATPases abrogated restoration of total cellular K+ content and 
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growth. Thus, these results provide mechanistic evidence for how small molecule ion 
channels rescue physiology.  
 Third, our findings suggest that imperfect small molecule mediated rescue of 
physiology is possible through functional collaboration with the cell’s inherent network of 
protein ion pumps and transporters. AmB and other polyene macrolide ion channels are 
unregulated, unrectified, unselective, and passive. However, we hypothesized that 
through working together with H+-ATPases (drivers) and transporters (correctors) that 
imperfect small molecule ion channels are sufficient to restore physiology. V-ATPase and 
Pma1 generate favorable electrochemical gradients. These gradients promote K+ flux 
through Trk1 and Trk2 and into vacuoles. We predicted that inhibiting V-ATPase or Pma1 
would abrogate small molecule mediated rescue of trk1Δtrk2Δ. To test our hypothesis, 
we employed three chemical inhibitors: Nocodazole (impedes microtubule dynamics), 
Bafilomycin (blocks V-ATPase), and Ebselen (inhibits Pma1) against small molecule ion 
channel treated WT and trk1Δtrk2Δ. We observed exceptional sensitivity in small 
molecule rescued trk1Δtrk2Δ cells to Bafilomycin and to Ebselen blockage compared to 
that observed in WT. In contrast, minor differences were observed between these two 
treatment groups, to Nocodazole inhibition. Therefore, these results suggest that cells 
require active V-ATPase and Pma1, possibly to drive K+ through small molecule ion 
channels, for rescue of trk1Δtrk2Δ cell growth. 
 Next, we hypothesized that endogenous protein transporters are crucial for 
correcting the lack of ion selectivity of small molecule ion channels. Yeast express plasma 
membrane localized voltage gated K+ efflux pump Tok1, Na+(K+)/H+ antiporter Nha1, and 
Na+-ATPase Ena1-5 that extrude excess K+ and Na+. We acquired a series of isogenic 
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yeast mutants and conducted the liquid broth rescue assay. We observed that small 
molecule mimics did not recover growth in trk1Δtrk2Δnha1Δ yeast for any concentrations 
screened. Importantly, the nha1Δ mutant showed similar growth to that of WT. In contrast, 
deletion of either Tok1 (trk1Δtrk2Δtok1Δ) or Ena1-5 (trk1Δtrk2Δena1-5Δ) did not hamper 
small molecule mediated rescue. Thus, these findings suggest that Nha1 is important for 
expelling excess Na+ and/or K+ from small molecule treated trk1Δtrk2Δ.  
 Last, in collaboration with The Mitchell Group, we have identified several potential 
and uncharacterized small molecule polyene macrolides through biosynthetic gene 
cluster analysis. We hypothesized through interrogating the gene clusters of several, 
highly conserved domains including the aminotransferase, ketosynthase, etc. that we can 
identify novel producing organisms of polyene macrolides. Through utilizing a moderate 
throughput yeast screening platform, we have found several organisms that produce 
extracts that may contain novel polyene macrolides.  
 In summary, this thesis work culminates into four major findings: first, small 
molecule mediated rescue is generalizable to other polyene macrolide family members; 
second, a primary mechanism by which small molecule ion channels rescue cell growth 
in trk1Δtrk2Δ yeast is through restored cellular K+ content; third, small molecule mimics 
work in conjunction with the cell’s inherent network of protein ion pumps and transporters 
to restore physiology; and last, we have identified several potential and uncharacterized 
polyene macrolides through biosynthetic gene cluster analysis. In conclusion, these 
results demonstrate the potential for imperfect small molecule mimics to provide function 
in the case of protein ion channel deficiencies. Furthermore, these findings showcase an 
in-depth mechanistic pathway for how imperfect small molecule mimics restore cellular 
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physiology in protein-deficient yeast. Intriguingly, the same protein characters responsible 
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CHAPTER 1: GENERAL INTRODUCTION 
 
Channelopathies represent one subset of human diseases caused by the 
dysfunction of and/or lack of expression of protein ion channels.1,2 They can affect 
different organs and systems of the body including that of the heart, kidneys, lungs, and 
nervous system, and manifest in debilitating and/or life-threatening diseases including 
Long QT syndrome, Bartter syndrome, Cystic Fibrosis, episodic ataxia, and chronic 
pain.3,4 Currently, more than 30 human channelopathies remain incurable,5 thus 
demonstrating the need for new therapeutic strategies. 
Most pharmacological treatments use small molecules that bind to and either 
block,6 or turn on protein activity.7 However, these strategies will not work in cases where 
there is no protein to target. Significant advances have been made in gene editing with 
CRISPR/Cas9 technology including promising outcomes in murine models of Duchenne 
muscular dystrophy,8,9 hereditary tyrosinemia,10 cataracts,11 and many others. Although 
CRISPR/Cas9 shows tremendous potential to provide therapeutic benefit, several 
challenges remain including the need for more effective methods to deliver viral vectors,12 
undesired activation of the immune system,13 and concerns over the lack of long-term 
safety data.14 An alternative strategy is to employ small molecules that autonomously 
albeit imperfectly perform protein function.15,16,17,18,19 Small molecules have several 
advantageous features including that they effectively penetrate cells, are less likely to 
trigger an immune response, and their synthesis is scalable to metric ton quantities.20 We 
questioned whether imperfect small molecule mimics of protein ion channels might be 
enough to restore physiology in a protein ion channel deficient system? 
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 To probe this question, we selected Saccharomyces cerevisiae (S.cerevisiae) as 
an outstanding model organism because this unicellular eukaryote is well-annotated,21 
genetically tractable22,23,24,25 with well-established techniques for constructing gene 
deletion strains,26 and amenable to cultivation in the lab. The yeast model organism has 
been widely utilized to characterize the pathophysiology of human diseases.27 Last, 
studies in yeast have illuminated several fundamental biological processes important to 
human health including cell cycle regulation,28 telomere maintenance,29 and vesicle 
trafficking.30,31 
We predicted that an imperfect small molecule ion channel that is unregulated, 
unselective, and unrectified might work through functionally interfacing the cells’ robust 
homeostatic mechanisms.32 Cells possess highly regulated and sophisticated 
mechanisms for maintaining ion homeostasis33 including the generation of 
electrochemical gradients through ATP-driven protein ion pumps,33 selective gating of ion 
channels,34 efflux of ions through voltage-gated channels,35 and sequestration of ions into 
vacuoles.36 Given this inherent and robust grid of ion regulatory proteins, we hypothesized 
that an imperfect small molecule mimic could work in concert with these endogenous 
proteins to restore physiology in a protein-deficient system (Figure 1). Consistent with 
our hypothesis, we found that an imperfect small molecule ion channel mimic, 
Amphotericin B (AmB) vigorously and sustainably restored physiology in a potassium (K+) 
transporter deficient yeast model system.37 Furthermore, our pharmacological and 
genetic studies suggest that small molecule mediated rescue depends on the contributing 
activities of protein ion pumps, Pma1 and V-ATPase to generate favorable driving forces 




Figure 1. Small Molecule Mimics Functionally Interface with Endogenous Networks 
of Protein Ion Pumps to Restore Physiology. A. In wild-type (WT) yeast, regulated 
networks of protein ion pumps Pma1 and V-ATPase power the movement of protons (H+) 
across cellular membranes, to generate favorable electrochemical gradients. These 
gradients promote secondary active transport of ions including potassium (K+) into cells. 
B. However, when a critical protein channel is not expressed or dysfunctional, this can 
lead to ion dysregulation and pathophysiology. C. An imperfect small molecule mimic of 
the missing protein ion channel could work in concert with the cell’s endogenous network 




 These findings hold exceptional promise for the betterment of human health, as 
we could envision applying this strategy for the treatment of many different types of 
protein deficiencies. The Online Mendelian Inheritance in Man (OMIM)38 states that there 
are 3,825 genes with a known “phenotype-causing mutation.” Coupled with our small 
molecule based strategy, we could potentially find new treatment options for patients 
suffering from deficiencies of scaffolding proteins, enzymes, and others. Furthermore, we 
can gain a better fundamental understanding of the primary functions of these proteins 
by employing small molecules as chemical probes. Thus, through both rigorous chemical 
and biological studies, we hope to contribute to our fundamental understanding of how 
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 To date more than 30 human channelopathies remain incurable,1 demonstrating 
the need for new therapeutic approaches. Although phenomenal efforts and advances 
have been made in the fields of gene therapy2 and protein replacement therapies,3 
treatment options for channelopathies are still limited. One untested strategy is to employ 
small molecule ion channels to partially perform the functions of these missing proteins. 
Small molecules possess several advantageous qualities including that they effectively 
penetrate cells, are less likely to trigger an immune response, and their synthesis is 
scalable to metric ton quantities.4 Given the potential to impact the health of many 
individuals world-wide, we asked whether imperfect small molecule mimics of missing 
protein ion channels are sufficient to restore physiology in protein ion channel deficient 
cells.  
 One prime example of an ion channel forming small molecule is the natural product 
Amphotericin B (AmB, Figure 2A and Figure 2B).5 For more than 60 years, medical 
providers have employed AmB as an effective and life-saving anti-fungal agent for 
patients suffering from invasive, systemic fungal infections.6 However, one major 
drawback of this pharmaceutical is its severe toxicity to the kidneys.7 Previously, many 
researchers had supported the hypothesis that AmB’s primary mechanism of yeast cell 




Figure 2. The Small Molecule AmB Associates with Sterols to Form Ion Channels 
or Membranous Aggregates.10 A. Chemical structures of AmB and yeast sterol, 
ergosterol. B. Two potential models of AmB small molecule ion channels. On the left, 
eight AmB molecules associate into a channel that pinches and spans the membrane. 
On the right, two AmB channels associate to span the membrane. C. Two hypotheses for 
AmB’s mechanism of cell killing, either through ion channel formation or sterol extraction. 
[This image was reproduced from Gray KC et al. (2012). Amphotericin primarily kills yeast 
by simply binding ergosterol. Proc. Natl. Acad. Sci. USA. 109(7): 2234-9.] 
 
 
 However, The Burke Group at The University of Illinois at Urbana-Champaign 
proposed an alternative hypothesis wherein AmB exerts its cell killing activity through 
sterol binding and extraction. With the goal of improving the therapeutic utility of AmB as 
an antifungal agent, the Burke Group sought to test this hypothesis. First, graduate 
students Kaitlyn Gray, Daniel Palacios, Ian Dailey, and Matthew Endo hypothesized that 
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sterol binding is critical for yeast cell killing. In yeast, the major sterol ergosterol plays a 
role in several critical processes for physiology including endocytosis, stabilization of 
membrane proteins,11 pheromone signaling, and vacuole fusion.12  
 To test this first hypothesis, they employed three chemical probes 
Amphoteronolide (AmdeB), Natamycin (Nat.), and Nat. aglycone (Figure 3A). AmdeB is 
a derivative of AmB that lacks the mycosamine sugar and was predicted to abolish sterol 
binding. Nat. is a known polyene macrolide that kills yeast but does not permeabilize 
cells.13 Deletion of the mycosamine sugar in Nat., also known as Nat. aglycone was 
predicted to eliminate cell killing activity.  
 Second, they hypothesized that loss of ion channel activity in AmB would not 
impact its antifungal activity. Taking note of modeling experiments that proposed the 
essential role of the C35 oxygen atom in AmB's capacity to form ion channels,14,15 they 
synthesized an AmB derivative that lacks an oxygen atom at the C35 position 
(C35deOAmB, Figure 3A). With these chemical probes in hand, they investigated AmB’s 







Figure 3. AmB Kills Yeast through Sterol Binding.10 A. Chemical structures of AmB, 
yeast sterol ergosterol, Amphoteronilide (AmdeB), Natamycin (Nat.), Nat. aglycone, and 
channel inactivated C35deOxyAmB (C35deOAmB). B. Isothermal titration calorimetry 
assays showed significant differences in the total exotherm for AmB to ergosterol-
containing LUVs vs. that of sterol-free LUVs. The same trend was observed in the case 
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Figure 3. (continued) 
of Nat. and for C35deOAmB. No differences were found in AmdeB to sterol-free LUVs vs. 
ergosterol-containing LUVs, nor for Nat. aglycone to sterol-free LUVs vs. ergosterol-
containing LUVs. C. Next, to investigate the permeabilizing capacitities of each of these 
small molecules, K+ efflux assays were performed in wild-type yeast. AmB promoted 
pronounced permeabilzation. No permeabilization was observed with any of the other 
small molecules. D. Miniminum inhibitory concentration (MIC) assays showed that in 
contrast to AmB, loss of the mycosamine sugar (as in AmdeB) led to a dramatic reduction 
in the potency of this derivative for cell killing against both Saccharomyces cerevisiae 
(S.cerevisiae) and Candida albicans (C.albicans). A similar effect was observed in the 
case of Nat., where removal of the mycosamine sugar (Nat. aglycone) led to a drastic 
increase in the MIC (i.e. loss of potency). Last, C35deOAmB still retained cell killing 
activity, albeit moderately reduced. E. At the MIC of AmB, the ratio of AmB to ergosterol 
was found to be higher in both S.cerevisiae and in C.albicans. [This image was 
reproduced from Gray KC et al. (2012). Amphotericin primarily kills yeast by simply 
binding ergosterol. Proc. Natl. Acad. Sci. USA. 109(7): 2234-9.]. 
 
 
 First, the authors investigated the sterol binding interactions of each of their small 
molecule probes. They employed isothermal titration calorimetry (ITC) assays which 
revealed significant binding interactions of AmB, Nat., and C35deOAmB to ergosterol (in 
ergosterol-containing LUVs) compared to that of the sterol-free LUVs (Figure 3B). In 
contrast, AmdeB and Nat. aglycone showed no differences in the total exotherm for 
ergosterol-containing vs. sterol-free LUVs (Figure 3B). These results demonstrate that 
the mycosamine sugar is critical for sterol binding activity. Furthermore, these findings 
show that channel inactivated C35deOAmB can still effectively bind ergosterol.  
 Next, they investigated how the loss of the C35 oxygen atom would affect channel 
formation and permeabilizing activity. Through performing K+ efflux assays in wild-type 
(WT) yeast (Figure 3C), they observed that AmB led to vigorous K+ efflux. In contrast, 
loss of the C35 oxygen atom caused a complete loss of AmB’s permeabilizing capacity 
when tested at 3 μM and even at a 10 X higher dose of 30 μM. Furthermore, control 
compounds Nat. and Nat. aglycone (lacking the mycosamine sugar) showed no K+ efflux.  
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 To evaluate for antifungal efficacy, the authors challenged each chemical probe 
against Saccharomyces cerevisiae (S.cerevisiae) and Candida albicans (C.albicans). 
They observed that in contrast to AmB which showed potent cell killing around 0.5 μM for 
S.cerevisiae and 0.25 μM for C.albicans (Figure 3D); cleavage of the mycosamine sugar 
(AmdeB) caused a dramatic reduction in the potency of AmB. Loss of the mycosamine 
sugar in AmdeB abrogated sterol binding and thereby yeast cell killing activity. A similar 
effect was observed in the case of Nat. Removal of the mycosamine sugar as in Nat. 
aglycone, led to a dramatic reduction in potency; the Nat. aglycone showed an MICs >500 
μM, in contrast to around 2-4 μM for Nat. Deletion of the C35 oxygen atom did not 
drastically impair its antifungal activity, wherein an MIC was observed around 3-4 μM. 
Thus, this channel inactivated derivative C35deOAmB still retained antifungal activity.  
 AmB killed cells only when the amount of AmB surpassed that of sterols16 (Figure 
3E). These results shed light on the importance of the ratio of AmB: sterol, for either ion 
channel or sterol binding activity. Through utilizing AmB at low doses below the threshold 
for cell-killing, we posit that we will primarily harness AmB’s ion channel activity. At higher 
doses, AmB binds sterols to promote yeast cell killing. Furthermore, pre-complexation of 
AmB with sterols may alleviate potential toxicity.17 In summary, sterol binding is critical 
for yeast cell killing as demonstrated by the dramatic loss of potency in the aglycone 
derivatives.  
 A second finding of this study was that the length of the polyene region impacted 
the ability for small molecule polyene macrolides to form ion channels. Nat. which 
contains four double bonds in the polyene region (tetraene) showed no cell 
permeabilization. In contrast, AmB which contains seven double bonds (heptaene) 
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exhibited substantial K+ efflux. Potentially, the core framework of tetraene, Nat. is 
insufficient to span the cell membrane for permeabilization. Current efforts are geared 
towards understanding the structure activity relationship (SAR) between polyene length 
and ion channel activity.  
 To further delve into elucidating AmB’s mechanism of yeast cell killing, graduate 
students Thomas Anderson, Mary Clay, Alex Cioffi, and Katrina Muraglia investigated 
how AmB binding and sequestration of sterols would impact cell physiology. Solid state 
nuclear magnetic resonance (SSNMR) studies revealed the localization of AmB outside 
of lipid membranes.16 Furthermore, transmission electron microscope (TEM) images 
showed the association of AmB aggregates to ergosterol containing monounsaturated 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes (Figure 4B).16 These 
structural studies demonstrated the propensity of AmB to self-aggregate and associate 
with lipid membranes.  
 
Figure 4. Transmission Electron Microscope Images of AmB Aggregates.16 A. 
Monounsaturated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes 
were prepared in a 10:1 ratio of POPC to ergosterol. B. Association of AmB aggregates 
to a POPC liposome (10:1 ratio of POPC to ergosterol). C. AmB aggregates. [Image from 
Anderson TM, et al. (2014). Amphotericin forms an extramembranous and fungicidal 




 Last, they examined how AmB-aggregates led to yeast cell killing. These 
aggregates not only associated with lipid membranes but extracted sterols from whole 
yeast cells (Figure 5A) within 30 minutes compared to that of AmdeB which does not 
bind sterols. In addition, the sterol extraction diminished the number of yeast colony 
forming units (CFUs, Figure 5B), demonstrating that sterol sequestration is sufficient to 
cause yeast cell killing. Furthermore, methyl-β-cyclodextrin (MβCD) which is a 
characterized sterol extractor led to significant sterol extraction and yeast cell killing 
(Figure 5C-D), in contrast to treatment with AmB-ergosterol complexes.  
 
Figure 5. AmB Aggregates Promote Yeast Cell Killing through Sterol Extraction.16 
A. Within 30 minutes, AmB removed ergosterol (Erg) from whole WT yeast. In contrast, 
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Figure 5. (continued) 
AmdeB did not extract ergosterol. B. AmB mediated ergosterol extraction led to yeast cell 
killing, while no effect was observed in AmdeB treated yeast. C. Methyl-β-cyclodextrin 
(MβCD) extracted ergosterol from whole WT yeast, while treatment with AmB-ergosterol 
complexes (AmB/Erg) did not. D. Positive control MβCD caused yeast cell killing, while 
ergosterol and AmB-ergosterol complex (AmB/Erg) showed no toxicity. [Image from 
Anderson TM, et al. (2014). Amphotericin forms an extramembranous and fungicidal 
sterol sponge. Nat. Chem. Biol. 10(5): 400-406.] 
 
 
 Through determining that AmB kills yeast by binding and extracting their sterols, 
The Burke Group distinguished this small molecule’s cell killing activity from its ion 
channel forming capability. Encouraged by this prospect that we could separate the two 
activities, we sought to investigate whether AmB and other ion channel forming polyene 
macrolides could serve as molecular mimics of dysfunctional or missing protein ion 
channels, to restore physiology. 
 
Results 
 Polyene macrolides are diverse and complex natural products (Figure 6).18 
Previous reports demonstrated differences in their lipid permeabilizing capacities, ion 
channel conductances, and ion selectivities.5,19 Encouraged by the prospect of 
harnessing AmB’s ion channel forming activity separate from its antifungal activity, we 
hypothesized that an imperfect small molecule ion channel mimic might be sufficient to 




Figure 6. Small Molecule Polyene Macrolide Family Members. Chemical structures of 
polyene macrolide family members Natamycin (Nat.), Nystatin (Nyst.), AmB, Candicidin 
(Can.), and Mepartricin (Mep.). These polyene macrolides have been shown to bind 
sterols. Nat. is a polyene macrolide that does not form ion channels but retains antifungal 
activity against yeast. Nyst., AmB, Can., and Mep. form ion channels in vivo.  
 
 
To test this hypothesis, we first investigated whether a low dose of AmB would 
restore growth in potassium (K+) transporter deficient (trk1Δtrk2Δ) yeast. We streaked 
agar plates containing standard amounts of K+ (approx. 10 mM KCl) with WT or 
trk1Δtrk2Δ yeast. Consistent with the genotypes of these yeast, we observed growth of 
WT cells (Figure 7A, left panel) and no growth of the trk1Δtrk2Δ cells (Figure 7A, middle 
panel).20 However, upon supplementing the plates with a low dose of AmB (125 nM final), 
we observed vigorous rescue of trk1Δtrk2Δ cell growth (Figure 7A, right panel).20 
 Next, we asked whether AmB rescue of trk1Δtrk2Δ cell growth was concentration 
dependent. To probe this question, we performed a disc-diffusion assay wherein 
trk1Δtrk2Δ yeast were streaked onto agar plates. Then sterile paper discs containing 
either DMSO control or AmB were placed onto the plates. No growth was observed 
around the DMSO control disc (Figure 7B, left disc). Distal or proximal to the AmB disc, 
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we saw no growth (Figure 7B, right disc); these correspond to AmB concentrations that 
are too low or too high (toxic) for cell growth. However, at intermediate distances from the 
AmB disc, where concentrations of this small molecule are moderate, we observed a zone 
of “functional complementation,” or rescued cell growth.   
 Next, we quantified the extent of small molecule mediated rescue by performing a 
liquid broth dilution assay. We observed poor growth of the DMSO control treated 
trk1Δtrk2Δ cells in contrast to the WT cells (Figure 7C). However, AmB vigorously 
restored growth of trk1Δtrk2Δ cells back to WT levels.20 
 Following, we investigated whether small molecule mediated rescue was 
sustainable. We iteratively cultured WT and trk1Δtrk2Δ cells between liquid broth and 
solid agar conditions (10 mM KCl final). We observed sustained AmB mediated rescue of 
trk1Δtrk2Δ cell growth for more than 40 days (Figure 7D). Importantly, removal of AmB 
from the trk1Δtrk2Δ culture led to a rapid loss of cell rescue, demonstrating the continued 




Figure 7. Imperfect Small Molecule Ion Channel Mimic, AmB Vigorously and 
Sustainably Rescued Mutant Cell Growth.20 A. On agar plates containing standard 
concentrations of K+, WT cells grew while trk1Δtrk2Δ cells did not. However, 
supplementing a low dose of AmB to the plates rescued trk1Δtrk2Δ cell growth. B. Disc 
diffusion assay results showed no growth of the trk1Δtrk2Δ cells around the paper disc 
containing vehicle (DMSO). In contrast, a robust zone of cell growth was observed around 
the AmB containing disc. C. UV-VIS quantification of liquid cultures showed that in 
contrast to WT cells, trk1Δtrk2Δ cells grew poorly. However, the addition of a low dose of 
AmB restored mutant cell growth back to WT levels. D. Last, small molecule mediated 
rescue was sustainable over the course of more than 40 days, wherein WT and AmB 
rescued trk1Δtrk2Δ cells were cultured iteratively between both liquid cultures and on 
solid agar plates. [Image reproduced from Cioffi AG, et al. (2015). Restored physiology in 




 After finding that small molecule mediated rescue is both vigorous and sustainable, 
we next probed whether AmB mediated rescue is ion channel dependent. Previously, our 
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lab synthesized a derivative of AmB wherein we deleted a single oxygen atom at the C35 
position, C35deOAmB (Figure 8A, right). This oxygen atom was predicted to be important 
for ion channel formation. To test this prediction, we performed a broth dilution assay. We 
hypothesized that since C35deOAmB is unable to form ion channels, it would no longer 
rescue cell growth. Consistent with our hypothesis, we observed no rescue of cell growth 
in the C35deOAmB treated trk1Δtrk2Δ cells up to 1 μM tested (Figure 8B). In contrast, 
AmB optimally rescued trk1Δtrk2Δ cell growth around 125 nM.   
 
Figure 8. Small Molecule Mediated Rescue is Ion Channel Dependent.20 A. To test 
the hypothesis that ion channel function is essential for small molecule mediated rescue 
of trk1Δtrk2Δ growth, a single atom deletion variant of AmB, C35deOAmB was utilized. 
C35deOAmB was previously shown to not permeabilize yeast. B. AmB restored growth 
in trk1Δtrk2Δ yeast around 125 nM. In contrast, C35deOAmB did not rescue growth 
across all concentrations tested up to 1 μM. C. Inhibition of AmB ion channels with bulky 
tetraethylammonium (TEA) abrogated AmB mediated rescue of trk1Δtrk2Δ growth. In 
contrast, TEA had no impact on the growth of trk1Δtrk2Δ cultured under permissive 
conditions (100 mM KCl). D. Last, similar 86Rb+ influx (surrogate tracer for K+) was 
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Figure 8. (continued) 
observed for both the WT and AmB rescued trk1Δtrk2Δ cells. In contrast, C35deOAmB 
treated trk1Δtrk2Δ cells showed no improvements in 86Rb+ influx compared to that of the 
DMSO control. [Image reproduced from Cioffi AG, et al. (2015). Restored physiology in 




Next, we further interrogated this ion channel dependence through employing two 
chemical probes. First, tetraethylammonium (TEA) is a known blocker of K+ channels.21 
We observed that in contrast to trk1Δtrk2Δ grown under permissive conditions of 100 mM 
KCl, TEA dose-dependently blocked rescue of AmB treated trk1Δtrk2Δ cells when tested 
under K+ limiting conditions (Figure 8C). Second, 86Rb+ is a surrogate tracer for K+.22 We 
observed that both WT and AmB treated trk1Δtrk2Δ cells showed similar 86Rb+ influx. In 
contrast, minimal influx was observed for the DMSO and C35deOAmB treatment groups 
(Figure 8D).  
 Encouraged by these results, we were fascinated by the possibility that this small 
molecule mediated approach could be generalizable to other small molecule ion channel 
formers. Many members of the polyene macrolide family have been shown to 
permeabilize lipid membranes.5,23 We sought to first reproduce the literature precedent 
and compare the permeabilizing capacities of several polyene macrolide candidates.  
 We employed a K+ selective probe and quantified the release of K+ from small 
molecule treated WT and trk1Δtrk2Δ cells. For each run, we recorded a 5-minute baseline 
before adding the DMSO control, or each small molecule compound. We noted minimal 
K+ efflux in DMSO treated WT cells (Figure 9). This baseline was inherent to the 
experimental set-up, and we terminated the experiment if the drift exceeded 15-20% 
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efflux for the DMSO control. For our negative control Nat., we observed minimal efflux 
(Figure 9).  
 
Figure 9. K+ Efflux in WT Yeast. Separate samples of WT yeast were treated 
individually with DMSO control or 3 μM final of Nat., AmB, Nyst., Can., and Mep., at 5 
minutes and monitored over time. 
 
 
However, we observed moderate K+ efflux from AmB and Nyst. treated WT and 
trk1Δtrk2Δ cells (Figure 9 and Figure 10). Can. (Figure 9 and Figure 10) and Mep. 
(Figure 9) promoted rapid efflux within 15 minutes. Valinomycin and Monensin showed 
minimal or no efflux respectively (Figure 10). 
 
Figure 10. K+ Efflux in trk1Δtrk2Δ Yeast. Separate samples of trk1Δtrk2Δ yeast were 
treated individually with DMSO control or 3 μM final of AmB, Nyst., Can., Valinomycin, 
and Monensin at 5 minutes. The K+ efflux was monitored over time.  
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Having demonstrated that other polyene macrolide family members could 
permeabilize yeast, we hypothesized that these ion channel forming small molecules 
could restore physiology in trk1Δtrk2Δ yeast. To test this hypothesis, we performed both 
disc diffusion and liquid broth dilution assays.  
For the disc diffusion assays, we utilized Nat. as a negative control since this small 
molecule does not permeabilize yeast. We observed no trk1Δtrk2Δ growth around the 
Nat. containing disc (Figure 11A). In contrast, small molecule ion channel formers AmB 
(Figure 11B), Nyst. (Figure 11C), Can. (Figure 11D), and Mep. (Figure 11E) all 
promoted rescue of trk1Δtrk2Δ cell growth; we observed rings of cell growth at 





Figure 11. Imperfect Small Molecule Ion Channel Mimics Restored Growth in 
trk1Δtrk2Δ Cells. Trk1Δtrk2Δ cells were streaked onto agar plates containing 10 mM 
KCl and sterile paper discs containing A. Nat., negative control at 4 mg/mL, B. AmB at 4 
mg/mL, C. Nyst. at 4 mg/mL, D. Can. at 4 mg/mL, E. Mep. at 4 mg/mL were applied. No 
growth was observed around the DMSO nor 1 M KCl control discs. Furthermore, Nat. 
which does not permeabilize yeast, did not restore cell growth. In contrast, the other ion 
channel forming small molecules, showed robust zones of restored cell growth around 
each of the compound containing discs. Images were taken at 24 hours. 
 
 
With these results in hand, we were interested in comparing the relative, optimal 
rescuing concentrations for each of these small molecule ion channel formers. Would 
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differences in the chemical structures of each of these small molecules impact the 
concentrations at which rescue of trk1Δtrk2Δ growth occurred? We predicted that the 
more potent permeabilizing small molecules Can. and Mep. would rescue growth at lower 
concentrations. First, as a negative control Nat. did not rescue trk1Δtrk2Δ cell growth 
under any concentration tested up to 3 μM, while toxicity in WT cells was observed above 
2 μM (Figure 12A). AmB was previously shown to restore physiology in trk1Δtrk2Δ yeast 
at 125 nM (data not shown). Consistent with our hypothesis, the more permeabilizing 
small molecule ion channel formers Can. and Mep. restored cell growth in trk1Δtrk2Δ 
yeast at 8 nM and 8 nM respectively (Figure 12C and D). While Nyst. which moderately 
permeabilized yeast, required a higher concentration of 1 μM (Figure 12B) for optimal 




Figure 12. Predicted Ion Channel Forming Small Molecules Rescued Yeast at 
Distinct Concentrations. A. Consistent with Nat.’s inability to permeabilize yeast, no 
growth was observed in the trk1Δtrk2Δ yeast across all concentrations tested up to 3 μM, 
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Figure 12. (continued) 
at 24 hours. In contrast, WT cells exhibited robust growth under these conditions, where 
cell killing was observed above 2 μM, graph represents the average of N = 3 independent 
experiments. B. Ion channel former, Nyst. vigorously rescued trk1Δtrk2Δ cell growth 
around 1 μM, at 24 hours. Representative graph is shown of N = 3 independent 
experiments. C. and D. Both Can. and Mep. restored physiology in yeast at around 8 nM, 
at 24 hours. For Can., graph represents the average of N = 3 independent experiments. 
For Mep., representative graph is shown for N = 3 independent experiments. 
 
 
To further test the hypothesis that ion channel function is critical for small molecule 
mediated rescue of trk1Δtrk2Δ cell growth, we investigated whether small molecule 
carriers and antiporters could be enough, to import adequate amounts of cations required 
for physiology. We found that other small molecule cation carriers Lasalocid (monovalent 
and divalent cation carrier)24,25 and Valinomycin (K+ selective carrier),26 and antiporters 
Monensin (Na+/H+ antiporter)27 and Nigericin (K+/H+ antiporter)28 (Figure 13)  
 
Figure 13. Chemical Structures of Small Molecule Carriers and Antiporters. Shown 
here are the chemical structures for carriers Lasalocid and Valinomycin, and antiporters 
Monensin and Nigericin.  
 
 
did not rescue growth in trk1Δtrk2Δ cells (Figure 14) in our disc diffusion assay. These 
results suggest that ion channel flux is critical for rescue of trk1Δtrk2Δ physiology. Future 
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studies will be conducted in spheroplasts (yeast cells with enzymatically removed cell 
walls) to determine whether the lack of activity of these small molecules could be due to 
physical cell wall barriers. 
 
Figure 14. Cation Carriers and Antiporters Did Not Restore Growth in trk1Δtrk2Δ 
Yeast. Neither cation carriers A. Lasalocid (163 μM) and B. Valinomycin (4 mg/mL) nor 
antiporters C. Monensin (4 mg/mL) and D. Nigericin (4 mg/mL) promoted growth in 
trk1Δtrk2Δ cells, by 24 hours. 
 
 
To rule out the possibility of poor diffusion in agar, we also tested Valinomycin and 
Nigericin in our liquid broth dilution assay. We observed no restoration of trk1Δtrk2Δ cell 
growth when tested up to the limits of solubility for both Valinomycin (Figure 15A) and for 
Nigericin (Figure 15B). Furthermore, other alkali metal ion transporters and ionophores 
did not promote rescue in trk1Δtrk2Δ cells (Figure 17); these findings provide further 
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evidence that ion channel mediated flux is critical for restoring physiology in this yeast 
system.  
 
Figure 15. Valinomycin and Nigericin Did Not Restore Physiology in trk1Δtrk2Δ 
Yeast. Neither A. Valinomycin nor B. Nigericin promoted trk1Δtrk2Δ growth by 24 hours. 
N=1 independent experiment for each. 
 
 
 Last, one major challenge of utilizing AmB is its toxicity caused by sterol binding. 
We hypothesized that pre-complexation of small molecules with host-sterols would 
ameliorate toxicity. To test this hypothesis, we prepared 5:1 ergosterol to small molecule 
complexes16 and evaluated these complexes for yeast cell killing. To quantify the 
reduction in toxicity, we performed a liquid broth dilution assay. In contrast to AmB 
(minimum inhibitory concentration, MIC = 0.5 μM), pre-complexation of ergosterol to AmB 




  We discovered that an imperfect small molecule mimic of a missing protein ion 
channel is enough to rescue physiology in a protein-deficient system. Furthermore, small 
molecule mediated rescue is vigorous, sustainable, and ion channel dependent. In 
addition, our small molecule mediated approach is generalizable to other polyene 
macrolide family members. These findings demonstrate the potential of employing 
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imperfect small molecule mimics to provide physiological benefit in cases of dysfunctional 
or missing protein ion channels in patients. 
 Future studies investigating the structure activity relationships of diverse small 
molecule ion channels and their ion conducting capacities and selectivities could enable 
the rational design of derivatives that favor the transport of cation or anion species. 
Furthermore, why does the presence of a p-amino benzoic acid (PABA) motif on both 
Can. and Mep. appear to enhance ion conductance, wherein we observed rescue of 
trk1Δtrk2Δ yeast at 8 nM compared to that of 125 nM for AmB (structurally similar 
compound that does not contain a PABA motif). Further studies probing the binding 
activity of these small molecules to sterols could shed light on potential differences in how 
these small molecules interact with cellular membranes.  
Last, investigation of the relationship between the length of the polyene region and 
ion channel activity could lead to insights on how these small molecules assemble into 
ion channels across cellular membranes. Nat. which contains four double bonds in the 
polyene region (tetraene) does not permeabilize yeast. Recently, we found that Eurocidin 
(contains five double bonds, pentaene) also does not promote trk1Δtrk2Δ rescue, 
suggesting a lack of channel activity. We are currently attempting to express a polyene 
macrolide with six double bonds in the polyene region (hexaene). We hypothesize that a 
polyene macrolide with six double bonds in the polyene region may be sufficient in length 
to form ion channels. 
 We are encouraged by our findings that pre-complexation of small molecules with 
host-sterols could prove as an effective strategy to reduce potential toxicity. These results 
greatly increase the utility of small molecule mimics as potential surrogates for missing 
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proteins, due to the larger range of therapeutic concentrations available. We are invested 
in better understanding the structures, binding strengths, and lipid membrane interactions 
of these sterol: small molecule complexes. Once in a living system, how stable are these 
complexes? Does exchange with endogenous sterols occur? 
Given the complexity of protein ion channels, it is fascinating that an unrectified, 
poorly selective, and unregulated small molecule ion channel surrogate could functionally 
interface with the cell to restore cell growth. Future studies investigating which 
endogenous proteins in cells play a role in facilitating small molecule mediated rescue, 
either through generating favorable electrochemical gradients or though correcting for the 
lack of ion selectivity of small molecule channels, may reveal conserved features in higher 
eukaryotes. 
 Excitingly in a higher eukaryotic system, Katrina Muraglia and Rajeev Chorghade 
demonstrated that a low dose of AmB could restore physiology in cystic fibrosis 
transmembrane conductance regulator (CFTR) deficient primary human lung epithelia.29 
This imperfect small molecule mimic rescued several hallmarks of lung physiology 
including airway surface liquid (ASL) pH, ASL antimicrobial activity, and viscosity. 
Mechanistically, they discovered that AmB mediated bicarbonate (HCO3-) transport led 
to restored physiology. Current efforts are geared towards investigating whether 
aerosolized AmBisome, a FDA approved liposomal formulation of AmB, could restore 
physiology in CFTR deficient pigs.  
 It is intriguing to consider the possibility of restoring physiology in other protein ion 
channel deficiencies. For example, voltage gated Na+ and K+ channel deficiencies impair 
important neurological functions.30 Dr. Yu-Qing Cao, from The Department of 
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Anesthesiology and Pain Center at Washington University in St. Louis studies TRESK K+ 
channels in primary afferent neurons. Through collaborative efforts, we are interested in 
investigating whether imperfect small molecules ion channels could potentially restore K+ 
conductance in these neurons and corresponding mouse models, for the treatment of 
chronic pain.  
Last, we posit that this small molecule based approach to restoring protein 
deficiency could expand beyond protein ion channel dysfunction. The next horizon would 
be to identify small molecules that mimic diverse protein functions. To date, The Online 
Mendelian Inheritance in Man (OMIM) Morbid Map reports 3,825 genes with a known 
“phenotype-causing mutation.” 31 In cases where protein replacement therapy and gene 
therapy are insufficient to provide therapeutic improvement, a small molecule based 
approach could benefit patient outcomes. For example, known enzymatic dysfunction 
affects several physiological processes including metabolism, collagen production, 
steroid hormone generation, and lysosomal storage.32,33,34,35 These manifest in diseases 
including phenylketonuria (dysfunctional phenylalanine hydroxylase),36 Ehler Danlos 
syndrome (lack of functional enzymes involved in collagen production),33 congenital 





Here, we discovered that imperfect small molecule ion channel mimics are 
sufficient to restore physiology in a protein-deficient system. Furthermore, we observed 
that small molecule mediated rescue is vigorous, sustainable, and ion channel 
dependent. Exploration into other polyene macrolide ion channels showed that this small 
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molecule based approach is generalizable, wherein PABA containing polyene macrolides 
Candicidin and Mepartricin showed effective permeabilization and rescued trk1∆trk2∆ cell 
growth at lower doses compared to that of non-PABA containing polyene macrolides AmB 
and Nystatin. Furthermore, pre-complexation of small molecules to native sterols proved 
to be an effective strategy to mitigate unwanted toxicity. It is intriguing to consider the 
possibility that imperfect small molecule mimics may be sufficient to restore physiology in 




For scientific contributions, Alex Cioffi performed the growth rescue assay 
development and discovery of AmB mediated rescue in trk1Δtrk2Δ yeast (Figure 7) and 
demonstrated that AmB mediated rescue is ion channel dependent (Figure 8). Jenn Hou 
performed the K+ efflux studies (Figure 9 and Figure 10), executed studies 
demonstrating that small molecule mediated rescue is generalizable to other polyene 
macrolides (Figure 11, Figure 12, Figure 14, and Figure 15), investigated other potential 
small molecule candidates (Figure 17), ran HPLC purification of AmB (Figure 18 and 
Figure 19), and determined the extinction coefficients of Nystatin A1 (Nyst.) and 
Candicidin (Can.) (Figure 20). 
 
Methods and Materials 
 
Yeast Media Conditions 
 
 The media was prepared as follows. For 1 L of 10 mM KCl YPAD pH 5.0 medium, 
we added 20 g of bactopeptone, 10 g of yeast extract, 15 mg of adenine hemisulfate to 
approximately 700 mL of milli-Q H2O. The base components of this medium contain 
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approximately 9.44 mM KCl and for simplicity we refer to this medium as 10 mM KCl or 
“normal” K+ medium. The medium was buffered with citric acid to a final pH of 4.9-5.0. 
For 1 L of 100 mM KCl YPAD pH 5.0 medium, we added 20 g of bactopeptone, 10 g of 
yeast extract, 7.44 g of KCl, 15 mg of adenine hemisulfate to approximately 700 mL of 
milli-Q H2O. Then we buffered the medium with citric acid to attain a final pH of 4.9-5.0. 
Next, we autoclaved the medium for 30 minutes. After, we added 50 mL of a 40% sterile 
dextrose solution per L of medium and filled the remaining volume with sterile milli-Q H2O 





 The yeast strains were maintained as frozen 15-20% glycerol stocks at -80°C. We 
streaked the yeast cell strains onto solid agar plates utilizing sterile inoculating loops. 
Then we grew the plates upside down in a 30°C incubator for 24-48 hours until single 
colonies were visible by eye. The plates were then wrapped in parafilm and kept upside 
down in a 4°C fridge. 
 
Yeast Disc Diffusion Assay 
This protocol was modified from The National Committee of Clinical Laboratory 
Standards document M2-A9.37 First to set up overnight cultures, we suspended 3-5 single 
colonies of WT and separately trk1Δtrk2Δ yeast into 1 mL each of 100 mM KCl YPAD 5.0 
medium. We then transferred this suspension to sterile 250 mL Erlenmeyer flasks 
containing 50 mL of 100 mM KCl YPAD and cultured overnight at 30°C, 200 X RPM. To 
harvest the cells, we centrifuged the saturated cell suspension at 500 X G for 5 minutes 
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at 23°C. Then we removed the supernatant and resuspended the cells in an equivalent 
volume of sterile milli-Q H2O, vortexed to mix, and then recentrifuged. We repeated the 
wash step. Following, we added 10 mM KCl YPAD to each cell pellet and vortexed to mix.  
 Next, we obtained an optical density (absorbance at 600 nm, OD600) ranging 
between 0.090-0.110 as measured by an ultraviolet-visible (UV-VIS) spectrophotometer. 
Following, we used sterile cotton applicators to apply each yeast strain onto 10 mM KCl 
YPAD agar plates. To do so, we dipped a sterile cotton applicator into the yeast cell 
suspension and streaked the whole agar plate. Then the plate was rotated 60° and a new 
cotton applicator was dipped and applied. We repeated this step for a total of 3 times and 
let the plates rest for 2-3 minutes. Then 10 μL of either DMSO control or small molecule 
solution was pipetted onto sterile 8 mm paper (Whatman 4) discs. Then the discs were 
transferred onto the plates. Or we applied the discs directly to the plates, and then let the 
plates rest for 10 minutes before pipetting 10 μL of solution per disc. The plates were 
allowed to rest before placing them upside down in a 30°C incubator for 36-48 hours.  
 As a control experiment, we investigated whether alkali metal ion transporters and 
ionophores restore physiology in K+ transporter deficient trk1Δtrk2Δ yeast (Figure 16). 
We observed no rescue with Beauvericin (alkali metal ion transporter),38 Nonactin 
(ammonium transporter),39 A23187 (Ca2+ transporter),40 magnesium ionophores I and III, 
and zinc ionophores I and IV (Figure 17). These results suggest that small molecule 




Figure 16. Chemical Structures of Alkali Metal Ion Transporters and Ionophores. 
Shown are the chemical structures for alkali metal ion transporter Beauvericin, and 
diverse ionophores including Nonactin (ammonium transporter), A23187 (calcium 




Figure 17. Alkali Metal Ion Transporters and Ionophores Did Not Restore 
Physiology in trk1Δtrk2Δ Yeast. No growth rescue was observed with A. Beauvericin 
(4 mg/mL), B. Nonactin (4 mg/mL), C. calcium ionophore A23187 (4 mg/mL), D.  
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Figure 17. (continued) 
magnesium ionophore I (4 mg/mL), E. magnesium ionophore 3 (4 mg/mL), F. zinc 
ionophore I (4 mg/mL), and G. zinc ionophore IV (4 mg/mL).  
 
 
Yeast Liquid Broth Dilution Assay 
 We followed the method reported in The Clinical and Laboratory Standards 
Institute document M27-A341 with the following changes. First, we utilized 10 mM KCl 
YPAD pH 5.0 for the medium source. Second, WT and trk1Δtrk2Δ yeast were treated with 
DMSO control or final concentrations of small molecules. The experiments terminated at 
24 hours and growth (optical density at 600 nm, OD600) was evaluated by UV-VIS.  
 
Tetraethylammonium (TEA) Blocking 
 We adapted the previously described yeast liquid broth dilution assay with the 
following modifications. First, trk1∆trk2∆ + 125 nM AmB yeast in 10 mM KCl YPAD, were 
treated with increasing doses of tetraethylammonium (TEA). Second, we also treated 
trk1∆trk2∆ yeast under nonlimiting K+ conditions (100 mM KCl YPAD) with increasing 
doses of TEA.  
 
86Rb+ Influx Assay 
 We made modifications to the protocol reported by Mulet et al.42 The day before 
the experiment, we prepared an overnight yeast culture. We harvested cells via 
centrifugation, decanted the supernatant, and washed the cells with sterile Milli-Q H2O. 
Following, we performed the wash step twice. Next, we subjected the cells to uptake 
buffer, (40 mL of 50 mM succinic acid, 2% glucose, adjusted to pH 5.5 with Tris) for three 
hours. Afterwards, we rinsed the cells twice with sterile Milli-Q H2O and transferred them 
in uptake buffer (1 mL). We quantified the cell counts with a hemocytometer (INCYTO) 
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and adjusted the cell density to 3 X 107 cells/mL. We transferred 0.7 mL of cells to an 
eppendorf tube and let the samples rest for 5 minutes in uptake buffer. We dosed cells 
with vehicle (DMSO), 3 μM of AmB, or 3 μM of C35deOAmB. Per tube, we spiked in 1.1 
μCi of 86RbCl and then thoroughly mixed the samples.  
 We quenched the reaction by combining 100 μL of sample with 10 mL of 20 mM 
MgCl2 (cold). We rapidly filtered the samples onto nitrocellulose membranes (0.45 μm, 
Millipore HAWP). We rinsed the cells twice with 15 mL of 20 mM MgCl2 (cold). Then we 
placed the membranes into scintillation vials. We determined the radioactivity (counts per 
minute, Perkin Elmer Wizard2 automatic ɣ counter) and the graph depicts averages from 
three biological samples.  
 
K+ Efflux Assay 
This protocol was modified from Palacios et al. (2011).43 Nonisogenic WT and 
trk1Δtrk2Δ yeast were cultured in YPD medium for 12 – 24 hours, at 200 X RPM, 30°C. 
10, 100, and 1000 ppm K+ standards (KCl) were prepared in Milli-Q H2O. Then 400 μL of 
5 M NaCl was added to 20 mL of each standard. 4 mL of each standard was aliquoted 
into 7 mL glass vials and small stir bars were added to each vial. We carefully rinsed out 
the inside of the K+ selective probe with the 1000 ppm standard (no NaCl added) and 
made sure not to puncture the valinomycin coated membrane. Following, we placed the 
K+ probe into a vial containing 1000 ppm K+ and equilibrated at 30°C, 150 RPM (with a 
stir bar). The 10, 100, and 1000 ppm K+ standards were also equilibrated for at least one 
hour. We prepared fresh 300 μM small molecule stock solutions in DMSO for Nat., AmB, 
Nyst., Can. (TOKU-E), and Mep. 
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 Then about 20 mL of saturated cell suspension was centrifuged at 300 x G, 23°C, 
for 5 minutes. We poured off the supernatant and then resuspended the cells in 20 mL of 
Milli-Q H2O. We vortexed to fully re-suspend the cell pellet. We repeated the wash step. 
Following, we re-suspended the cell pellet in 150 mM NaCl, 5 mM Hepes, pH 7.4 to an 
OD600 between 1.4 to 1.6. Afterwards, we transferred 3 mL each of cell suspension into 
separate 7 mL glass vials and equilibrated for at least 15 minutes at 30°C, 150 X RPM.  
 After equilibrating the cell suspensions and standards and calibrating the 
instrument, we first ran a DMSO control run. The probe was placed into a vial containing 
the yeast cell suspension and data points were recorded every 30 seconds for the first 6 
minutes. Following, we rapidly pipetted 30 μL of DMSO into the sample vial. We recorded 
the next 30 minutes of data. Next, to obtain maximum efflux from the cells, we injected 
30 μL of a 1% (w/v) digitonin solution; we recorded the following 15 minutes of data. Once 
the DMSO control drift was determined to be less than 10-15% of the total K+ efflux, we 
went ahead with the remaining samples and made sure to rinse the probe with Milli-Q 
H2O between each sample.   














S 100  
 
[K]t = potassium concentration at time t 
[K]0 = potassium concentration at time 0 
S = scaling factor 
 
wherein we determined the scaling factor by taking [K]t as the ppm value 15 minutes post-
digitonin treatment and [K]0 as the ppm value 1 minute after starting the run. Next, we 




High-Performance Liquid Chromatography (HPLC) of AmB 
 This method was based on our in-house protocol. The evening before HPLC 
purification, at least 8 - 10 L of acetonitrile and 8 – 10 L of 15 mM ammonium acetate 
were filtered through 0.2 μm filters. The day of the purification, we loaded the HPLC 
ammonium acetate, acetonitrile gradient method (MME_JH_Method) and rinsed the 
HPLC SunFire Prep C18 OBD column (30 x 150 mm) for at least 15 minutes. During this 
time, we allowed a bottle of AkScientific Amphotericin warm to room temperature and 
then prepared a 3 mg/mL solution in DMSO. We sonicated and vortexed the solution to 
fully suspend the Amphotericin. The solution was a dark yellow-orange color. The 
Amphotericin solution was filtered through iso-disc syringe tip filters and transferred to 
HPLC vials. 
For the first run, we programmed the instrument to inject 400 μL of DMSO to clean 
the column of any residual impurities. Once we observed that the spectra were clean at 
406 nm and 383 nm, then we injected 400 μL of Amphotericin stock solution. There was 
typically about a one minute separation between Amphotericin A and Amphotericin B 
(AmB) peaks. We manually collected the second large peak containing AmB (typically 
around 15.8 – 16.25 minutes, but this varied day to day). Following, we programmed the 
instrument to auto-inject, and we manually collected the AmB peak. We typically ran 10 
– 14 injections and collections per day to obtain a worthwhile amount of AmB per 
purification. 
After the last HPLC run, we then pulled off the acetonitrile and ammonium acetate 
by rotary evaporation. The remaining yellowish solution (almost paint-like) was 
resuspended in about 20-30 mL of Milli-Q H2O and toluene (from the solvent dispenser 
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system) to azeotrope the Amphotericin. This solution was roto-vaped. We repeated the 
azeotroping step two more times. For the last step, the AmB was resuspended in dimethyl 
sulfoxide-d6, transferred into pre-weighed 1.5 mL glass vials, and frozen. Then the 
samples were lyophilized for at least 24 hours or until completely dry. The AmB vials 
(Figure 18) were purged with either nitrogen or argon, wrapped with parafilm, stored in a 
container with desiccant, protected from light, and then stored at -20°C.  
 
 
Figure 18. HPLC Purified AmB. After lyophilization, AmB appeared as a sunflower 
yellow powder that was consistent in texture and not hygroscopic. Samples were 
aliquoted to avoid unnecessary exposure to atmospheric air. 
 
 
Analytical HPLC of AmB 
 The analysis of the purity of AmB was determined on an analytical HPLC (Figure 
19) with a SunFire C18 column (5 μm). The same gradient system was used as in the 
purification of AmB. A control standard of previously purified AmB was utilized to 
determine the retention time. For biological assays, we utilized purified AmB that had ≥ 




Figure 19. Representative Analytical HPLC Analysis of Purified AmB. Analytical 
HPLC analysis showed a single major peak of purified AmB for both 406 nm (top) and 
383 nm (bottom). The retentions times were found to match those of a known AmB 
standard (data not shown).  
 
 
Determination of Nystatin and Candicidin Extinction Coefficients 
This protocol was modified from Palacios et al. (2011).43 First, we determined the 
weight of the glass vials to be used. To do so, 4 mL glass vials were carefully rinsed with 
hexanes and then acetone, and oven dried at 120°C for several hours. Next, we allowed 
the glass vials to rest on the bench top until cool to the touch. At The UIUC Microanalysis 
Lab, we measured the weight of each vial. Care was taken to ensure that there were no 
finger marks on the glass vials and a static gun was applied before each measurement. 
Three weight measurements were obtained for each vial and the average was determined 
for each vial ± 10%. 
 Second, the desired compounds of interest (more than 1 mg per sample per vial) 
were dissolved in deuterated DMSO-d6, added to each vial, and frozen. Following, the 
samples were lyophilized overnight until all the solvent was removed. Next, the weight of 
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each vial was determined as previously described, and the average of three 
measurements was collected for each vial.  
 Following, we prepared a 1 mM stock solution in DMSO-d6 for each compound of 
interest and then generated 20 μL aliquots for each of the following dilutions: 800, 500, 
300, 100, and 50 μM. Afterwards, we took each of the aliquots and mixed 5 μL with 500 
μL of MeOH in triplicate for each concentration. Then on the UV-VIS spectrophotometer, 
we obtained spectra from 300 to 500 nm. We graphed the relative absorbance (at λmax) 
and used the slope to determine the extinction coefficient for both small molecules 
(Figure 20), where the R2 > 0.96 for both Can. and Nyst. For Can., we found that the λmax 
= 377.5 nm and the extinction coefficient is 33633 M-1 cm-1. For Nyst., the λmax = 304 nm 
and the extinction coefficient is 51207 M-1 cm-1. 
 
Figure 20. Determination of the Extinction Coefficients for Small Molecule Ion 
Channels Candicidin and Nystatin. The extinction coefficients were obtained for both 
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CHAPTER 3: SMALL MOLECULE ION CHANNELS RESTORE PHYSIOLOGICAL 





Ion homeostasis is a critical cellular process across all kingdoms of life.1,2,3 The 
dysregulation of ion flow and storage can result in devastating consequences for living 
systems.4,5 Preliminary studies demonstrate that an imperfect small molecule ion channel 
mimic could provide enough ion transport function to restore physiology in both yeast6 
and in human cells.7 With this discovery in hand, we sought to better understand 
mechanistically how passive and unrectified small molecule ion channel mimics could 
rescue physiology in potassium (K+) transporter deficient (trk1Δtrk2Δ) yeast.  
 K+ is important for several aspects of cellular physiology8 including: promoting 
enzyme activity, retaining intracellular pH, and sustaining plasma membrane 
potential.9,10,11,12,13 Yeast possess two primary K+ transporters, Trk1 and Trk2 which are 
localized to the plasma membrane.14,15,16 Trk1 and Trk2 transporters require an 
electrochemical gradient to drive K+ into cells.2 This electrochemical gradient is generated 
through the activity of H+-ATPases Pma1 and V-ATPase, which hydrolyze ATP to drive 
protons (H+) out of the cell or into vacuoles respectively, thereby producing favorable 
electrochemical gradients.13 Pma1 and V-ATPase are able to create electrochemical 
gradients which promote K+ flow through Trk1 and Trk2 transporters into cells to attain 
cytosolic concentrations around 200-300 mM2 and cation storage into vacuoles.13 
 Previous reports demonstrated that when trk1Δtrk2Δ cells were grown under 
ample K+ conditions (50 mM KCl), they showed total cellular K+ content near 500 nmol 
K+/mg cells, which was comparable to that observed in WT cells.17  However, when 
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trk1Δtrk2Δ cells were cultured under conditions of K+ limitation (5 mM KCl), after 10 hours 
their total cellular K+ content decreased dramatically to around 300 nmol K+/mg cells.17 
Loss of function of the integral Trk1 and Trk2 K+ transporters18 caused yeast cells to not 
be able to growth under standard lab conditions of 10 mM K+.19  
We propose the following mechanistic framework for how imperfect small molecule 
ion channel mimics restore physiology in protein-deficient yeast (Figure 21). First, it is 
well accepted that endogenous H+ pumps (drivers) generate favorable electrochemical 
gradients across cellular membranes. Furthermore, several groups have demonstrated 
that these electrochemical gradients persist in trk1Δtrk2Δ yeast, resulting in the 
hyperpolarization of these cells.2 Next, we hypothesize that passive and unselective small 
molecule ion channel mimics can harness these gradients to promote ion movement back 
to physiologically relevant levels, to restore physiology. These studies will provide insights 
into how small molecule surrogates act in concert with cellular networks of protein ion 






Figure 21. Schematic for the Proposed Pathway for Imperfect Small Molecule 
Mediated Rescue of Physiology. Yeast lacking K+ transporters are hyperpolarized and 
have functional H+-ATPases Pma1 and V-ATPase. These H+ pumps generate favorable 
electrochemical gradients by pumping H+ out of cells and into vacuoles respectively. 
These gradients are hypothesized to power ions (including K+) though imperfect small 
molecule ion channels. Small molecule mediated movement of K+ is predicted to increase 
intracellular K+ levels back to physiologically relevant values and thereby lead to the 
restoration of cell growth. Furthermore, Tok1 (a voltage-gated K+ efflux channel), Nha1 
(an antiporter), and Ena1-5 (Na+ efflux pumps) participate in ion regulation through 





Under conditions of K+ limitation, trk1Δtrk2Δ yeast are hyperpolarized when 
compared to WT.2,3 Our findings of hyperpolarization in trk1Δtrk2Δ yeast when grown 
under K+ limiting conditions (Figure 22) are consistent with prior reports. Additionally, we 
found that the cells remained hyperpolarized across all time points tested up to 12 hours. 
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Encouraged by these results, we predicted that these inherent electrical gradients across 
cellular membranes (Figure 22) could be harnessed by cells, to drive ion movement 
through passive small molecule ion channels. Specifically, we hypothesized that ion 
channel forming small molecules would promote increased intracellular K+ content in 
trk1Δtrk2Δ yeast, thereby restoring cell growth and physiology. To test this hypothesis, 
we treated WT and trk1Δtrk2Δ yeast with small molecule ion channels Amphotericin B 
(AmB) and Nystatin A1 (Nyst.),20 and quantified the total cellular K+ content.  
 
Figure 22. K+ Transporter Deficient Yeast are Hyperpolarized. After transferring the 
yeast from 50 mM KCl to 15 mM KCl Yeast Nitrogen Base (YNB) medium and incubating 
with membrane potential dye 3,3-dipropylthiacarbocyanine iodide (DiSC3(3)), trk1Δtrk2Δ 
cells showed hyperpolarization (greater I580/I560), over the course of 12 hours tested. N > 
6 samples for 0 hours, N > 11 samples for 6 hours, N = 12 samples for 9 hours, and N > 
11 samples for 12 hours, over N ≥ 3 independent experiments. *P ≤ 0.05, ****P ≤ 0.0001. 
 
 
First as a negative control, we employed Natamycin (Nat.) which is a small 
molecule polyene macrolide that does not permeabilize cells nor rescue trk1Δtrk2Δ cell 
growth. Consistent with previous results, we observed no restoration of cell growth in 
trk1Δtrk2Δ when tested up to 1 μM (Figure 23A). In the DMSO control, we observed a 
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significant decrease in the total cellular K+ content at 24 hours in trk1Δtrk2Δ yeast (around 
200 nmol K+/ mg cells, via inductively coupled plasma-mass spectrometry (ICP-MS) 
compared to that of WT (around 400 nmol K+/ mg cells) when tested under conditions of 
K+ limitation (15 mM KCl YNB pH 5.8) (Figure 23D). These results highlight the major 
role that Trk1 and Trk2 play in enabling cells to import K+. In contrast, AmB small molecule 
ion channels dose-dependently rescued cell growth in trk1Δtrk2Δ yeast, with optimal 
rescue observed at 100 nM (Figure 23B). Furthermore, increases in restored cell growth 
correlated with a significant and dose-dependent rise in K+ levels for AmB rescued 
trk1Δtrk2Δ cells (Figure 23E). Similar results were observed for both Nyst. rescue of cell 
growth (Figure 23C) and K+ content (Figure 23F). Importantly across all concentrations 
tested, Nat., AmB, and Nyst. did not perturb the K+ levels in WT cells.  
 
 
Figure 23. Imperfect Small Molecule Ion Channels Dose-Dependently Rescued Cell 
Growth and Restored Cellular K+ Content in Protein-Deficient Yeast. A. In the 
absence of any small molecule added, trk1Δtrk2Δ cells showed limited growth compared 
to that of WT at 24 hours, under conditions of K+ limitation (15 mM KCl Final YNB, pH 
5.8). Nat. did not promote cell growth across all concentrations tested (up to 1 μM). N =  
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Figure 23. (continued) 
3 independent experiments at 24 hours. B. In contrast, AmB dose-dependently promoted 
cell growth in trk1Δtrk2Δ with optimal rescue occurring at 100 nM. N = 3 - 8 independent 
experiments at 24 hours. C. Nyst., a second example of an ion channel forming small 
molecule also restored growth (optimally at 1 μM), and reached values similar to that 
observed in WT cells. N = 3 independent experiments at 24 hours. D. Consistent with its 
inability to form ion channels, Nat. did not promote increased total cellular K+ content, 
even when tested at the highest dose of 1 μM. E. In contrast, AmB dose-dependently and 
significantly elevated total cellular K+ content. F. Similar results were observed for Nyst., 
wherein K+ levels were found to be similar to those of WT. Importantly for both AmB and 
for Nyst. treated WT cells, the presence of either of these small molecules did not perturb 
the total cellular K+ content and levels remained consistent around 400 – 500 nmol K+/ 
mg of cells. NS = not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. 
 
 
 Next, we asked whether small molecule mediated restoration of ion content was 
sustained over time. To interrogate this question, we selected the optimal rescuing 
concentration of each small molecule ion channel and evaluated the growth and K+ 
content as a function of time. Again, we employed Nat. as a negative control. We 
observed no improvements in trk1Δtrk2Δ cell growth upon 100 nM Nat. treatment across 
all time points evaluated (Figure 24A). Through ICP-MS analysis, we noted that WT cells 
accumulated more K+ over time (Figure 24D). Trk1Δtrk2Δ showed minor increases in K+ 
content by 24 hours. The addition of 100 nM Nat. to trk1Δtrk2Δ cells did not raise the total 
cellular K+. Even when Nat. was tested at a higher dose of 1 μM final, we did not observe 
improvements in trk1Δtrk2Δ cell growth nor total cellular K+ content (data not shown).  
 Second, we investigated whether AmB small molecule ion channels would 
promote increased K+ content over time. We observed that 100 nM AmB rescued 
trk1Δtrk2Δ cell growth back to that of WT levels by 12 hours (Figure 24B). Consistent 
with our hypothesis, we observed that AmB small molecule ion channels led to significant 
increases in the total cellular K+ content over time (Figure 24E), reaching levels close to 
that observed in WT. Similar results were observed for Nyst. mediated rescue of cell 
51 
 
growth (Figure 24C); and we found concurrent increases in total cellular K+ content 
(Figure 24F) in trk1Δtrk2Δ cells that was sustained over the course of 24 hours.  
 
 
Figure 24. Small Molecule Ion Channel Mimics Sustain Ion Transport and Restored 
Growth over Time in Protein-Deficient Yeast. A. Negative control Nat. (100 nM) did 
not re-establish cell growth over the course of 24 hours in trk1Δtrk2Δ cells compared to 
that of WT (N = 3-4 independent experiments). B. AmB (100 nM) promoted trk1Δtrk2Δ 
growth back to WT levels over time (N = 5 independent experiments). C. Nyst. (1 μM) 
also restored growth in trk1Δtrk2Δ cells by 12 to 24 hours (N = 3 independent 
experiments). D. ICP-MS analysis showed that WT cells increased total cellular K+ 
content over time commensurate with cell growth, reaching values near 400-500 nmol 
K+/mg cells. Nat. did not improve K+ levels in trk1Δtrk2Δ cells compared to that of the 
DMSO control with values near 200 nmol K+/mg cells. E. In contrast, 100 nM AmB 
treatment promoted increased total cellular K+ content in trk1Δtrk2Δ cells back to WT 
levels, over time. F. Similar results were found for 1 μM Nyst., where small molecule 
rescued trk1Δtrk2Δ cells exhibited elevated and sustained total cellular K+ content. NS 
not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. 
 
 
 Since endogenous H+ pumps V-ATPase and Pma1 are important for generating 
favorable electrochemical gradients, we predicted that chemical inhibition of these pumps 
would disrupt these gradients, reduce the driving force for small molecule mediated 
transport of ions, and thereby diminish overall cellular K+ content. To test this hypothesis, 
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we employed chemical inhibitors Bafilomycin B1 and Ebselen, a V-ATPase blocker21 and 
Pma1 inhibitor22 respectively, and monitored their effect on small molecule rescued cells.  
 We observed that AmB rescued trk1Δtrk2Δ cells showed increased sensitivity to 
Bafilomycin inhibition compared to that of AmB treated WT cells (Figure 25A). 
Furthermore, we saw a dose-dependent decrease in the total cellular K+ content for both 
treatment groups at 12 hours (Figure 25C). The cells did not recover over the course of 
the experiment, and inhibition of both cell growth and K+ content was sustained even up 




Figure 25. Chemical Inhibition of Ion Pumps is Detrimental to Cell Growth and 
Results in Diminished K+ Content. A. Bafilomycin and B. Ebselen dose-dependently 
blocked cell growth in both AmB treated WT and AmB rescued trk1Δtrk2Δ cells at 12 
hours. These inhibitors, C. Bafilomycin and D. Ebselen also reduced the total cellular K+  
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Figure 25. (continued) 
content in AmB treated WT and AmB rescued trk1Δtrk2Δ cells, at 12 hours. N = 3 - 5 
independent experiments for Bafilomycin B1. N = 3 - 4 independent experiments for 
Ebselen. NS = not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. 
 
 
 Ebselen inhibited cell growth (Figure 25B) and decreased the total cellular K+ 
content (Figure 25D) in both treatment groups. Current efforts are geared towards 
utilizing a more selective Pma1 inhibitor, to determine whether differences in sensitivity 




 We found that imperfect small molecule ion channels can functionally interface 
with the cells’ endogenous network of protein ion pumps, to restore ion content and 
physiology. Specifically, our studies further support that H+-ATPases V-ATPase and 
Pma1 are important for generating favorable electrochemical gradients. Our data suggest 
that cells can harness these gradients to drive K+ ions through imperfect small molecule 
ion channels, back to physiologically meaningful levels for cell growth. Furthermore, 
blocking either V-ATPase or Pma1 diminished small molecule mediated K+ uptake and 
thereby cell growth.  
 Intriguingly, the total cellular K+ content in small molecule rescued trk1Δtrk2Δ cells 
was found to be similar to that in WT. These observations suggest that mechanisms of 
ion homeostasis remain active in small molecule rescued trk1Δtrk2Δ cells, albeit these 
imperfect small molecule ion channels are poorly selective and not regulated. Future 
studies quantifying the total cellular ion content of other ions23 that polyene macrolides 
are known to transport, including H+, Na+, and Cl- would provide insights into the dynamic 
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responses of cells to these imperfect ion channels and cellular regulation of ion 
movement.  
 Furthermore, could the inherent protein framework of electrogenic ion pumps that 
generate favorable gradients for small molecule ion channels, be broadly applicable 
across many different vertebrate systems? These small molecule ion channel mimics 
could serve as invaluable probes to investigate these ion gradients and protein drivers, in 
other cellular systems. In addition, it is fascinating to consider whether this approach of 
using imperfect small molecule ion channels could expand beyond that of ion channels 
and carriers. Future studies with diverse small molecule mimics that perform different 
functions (enzyme catalysis, protein scaffolding, etc.) would provide further evidence for 
the generality of this small molecule approach. 
 
Author Contributions 
For scientific contributions, Page N. Daniels developed the membrane potential 
assay, based on literature precedent. Jenn Hou performed the membrane potential assay 
(Figure 22), and developed and conducted the dose- and time-dependent studies 
(Figure 23 and Figure 24) for total cellular K+ content and for the chemical inhibition 
studies (Figure 25). Dr. Kiran Subedi contributed to the inductively coupled plasma-mass 
spectrometry (ICP-MS) experimental design and with Crislyn Lu performed the ICP-MS 
analysis for all reported data. 
 
Methods and Materials 
Membrane Potential Determination and Statistical Analysis 
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 We measured the membrane potential as previously described.2,24 Briefly, both 
WT and trk1∆trk2∆ yeast were cultured overnight in 50 mM KCl supplemented YNB, pH 
5.8. Following, the cells were harvested, washed twice with sterile Milli-Q H2O, and re-
suspended in 15 mM KCl supplemented YNB, pH 5.8. Under a sterile field, the cells were 
diluted to an OD600 of 0.2 and incubated for the indicated times. We prepared multiple 
sample tubes, per designated time point. At each time point, we checked the OD600 values 
of the samples and diluted the cells to an OD600 of 0.2 if necessary. An aliquot of each 
sample was pipetted into a 96-well black microplate. 3,3-dipropylthiacarbocyanine iodide 
(DiSC3(3)) dye was added to the wells to a final concentration of 0.2 µM. The samples 
were incubated for 30 minutes (at 200 X RPM, 30°C). A fluorescence spectrum with 
excitation at 531 nm and emission from 549-589 nm, was taken on a BioTek Synergy H1 
microplate reader. The ratio of 580 nm/560 nm was recorded for each sample. Results 
show the average of at least N = 6 biological replicates per time point, for ≥ 3 independent 
experiments total. For statistical analysis, we compared the two yeast strains at each time 
point, with the unpaired t-test.  
 
Large Scale Rescue Assays and Statistical Analysis 
Dose-Response 
 5 single colonies of isogenic WT and trk1Δtrk2Δ yeast were cultured overnight in 
100 mL each of 100 mM KCl YNB medium pH 5.8, 200 X RPM, 30°C. During the day of 
the experiment, AmB was freshly prepared. A clean pasteur pipette was used to add a 
small amount of AmB to 2 mL of DMSO. The solution was briefly vortexed and sonicated. 
Then a 1 mL gastight syringe was utilized to add a total of 1.998 mL of methanol (MeOH) 
to three separate glass vials. Following, we added 2 μL of the AmB solution to dilute the 
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sample 1:1000 fold. Next, we blanked the UV-VIS instrument with MeOH across 
wavelengths from 300-450 nm and determined the absorbance at 406 nm. Care was 
taken to ensure that the absorbance values were within 5-10% of the average and more 
samples were prepared and measured if needed. The Beer-Lambert Law A = εcl was 
employed to determine the concentration of the solution with ε = 164,000 M-1cm-1 for AmB, 
l = 1 cm; and we accounted for the 1,000-fold dilution factor. Once the concentration of 
AmB was determined, we prepared a 6 mL solution of 80 μM. Then the following dilutions 
were prepared as indicated in Table 1. 
Table 1. AmB Dilution 
Initial Concentration (μM) 0 0.4 2 4 
Final Concentration (μM)  0 0.01 0.05 0.1 
Amount of 80 μM AmB to Add 0 0.03 mL 0.15 mL 0.3 mL 
Amount of DMSO to Add 
(2.5 mL 
per flask) 5.97 mL 5.85 mL 5.7 mL 
 
The same protocol was followed for Nystatin A1, except the UV-VIS instrument 
was blanked with MeOH for wavelengths from 250-450 nm. The absorbance values were 
determined at λmax of 304 nm, and the concentration was determined where the ε = 51,207 
M-1cm-1. Following, we prepared a 120 μM Nystatin A1 solution and made the following 
dilutions in DMSO as indicated in Table 2. 
Table 2. Nystatin A1 Dilution 
Initial Concentration (μM) 0 4 10 20 40 
Final Concentration (μM) 0 0.1 0.25 0.5 1 
Amount of 120 μM Nystatin 
A1 to Add 0 0.2 mL 0.5 mL 1 mL 2 mL 
Amount of DMSO to Add  
(2.5 mL 




For Natamycin, the UV-VIS instrument was blanked with MeOH for wavelengths 
from 250-450 nm. The absorbance values were determined at λmax of 317 nm, and the 
concentration was determined where the ε = 76,000 M-1cm-1. Following, we prepared a 
120 μM Natamycin solution and made the following dilutions in DMSO as indicated in 
Table 3.  
Table 3. Natamycin Dilution 
Initial Concentration (μM) 0 0.4 4 20 40 
Final Concentration (μM) 0 0.01 0.1 0.5 1 
Amount of 120 μM 
Natamycin to Add 0 0.02 mL 0.2 mL 1 mL 2 mL 
Amount of DMSO to Add  
(2.5 mL 
per flask) 5.98 mL 5.8 mL 5 mL 4 mL 
 
 Then between 18-24 hours when both cell cultures were saturated, we harvested 
90 mL for both WT and trk1Δtrk2Δ cultures by centrifuging at 1000 X G, 5 minutes, 23°C. 
We removed the supernatant, resuspended the cells in equal volumes of sterile Milli-Q 
H2O and recentrifuged the samples. The wash step was repeated. This time, we 
resuspended the cells in 5-10 mL of 15 mM KCl YNB pH 5.8 and combined each 
respective strain into one conical tube. The cell suspensions were briefly vortexed. 
Afterwards, we blanked the UV-VIS instrument with an empty cuvette for spectra from 
590-610 nm. Under the sterile field of the Bunsen burner, the cell suspensions were 
diluted to an OD600 value between 0.090 – 0.110 (after allowing the samples to rest for 2-
3 minutes). We prepared at least 0.7 L of cells suspension at these absorbance values 
for both strains.  
 Next, we carefully poured about 0.25 L of each cell suspension into sterile 
graduated cylinders to coat the inner surface, working with one strain at a time. Then we 
poured this cell suspension back into the original 1 L bottle. Next, we measured out 0.1 L 
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total of cell suspension and transferred this to a clean and labeled 0.25 L Erlenmeyer 
flask. This step was repeated for the remaining flasks and the bottle was inverted between 
each aliquot to ensure that the cells did not settle to the bottom. The same was done for 
the other stain.  
 Next, we swirled each flask and removed 2.5 mL of cell suspension from each flask 
using clean serological pipettes. Following, 2.5 mL of DMSO or small molecule solution 
was added to each flask. The order of the strains poured and small molecule treatment 
doses was alternated for different experimental runs to avoid introducing bias. The flasks 




 We performed the same overnight culture set-up as described for the dose-
response experiments. To prepare the Nat. stock solution, the concentration was 
determined as previously described. This time, we prepared 14 mL of a 4 μM solution 
(with a final concentration of 0.1 μM). We also prepared 14 mL of a 40 μM solution (with 
a final concentration of 1 μM) for the higher-dose experiment. For AmB, we generated 14 
mL of a 4 μM solution (with a final concentration of 0.1 μM). Last, for the Nystatin A1 stock 
solution, we made 14 mL of a 40 μM solution (with a final concentration of 1 μM).  
When the cells were saturated between 18-24 hours, we harvested 90 mL of each 
strain at 1000 X G, 5 minutes, 23°C. Then the supernatant was poured off and the cells 
were resuspended in equal volumes of sterile Milli-Q H2O. The cells were briefly vortexed 
to fully resuspend the cell pellets. Afterwards, we recentrifuged the samples. We repeated 
the wash step. This time, the cell pellets were resuspended in 15 mM KCl YNB pH 5.8 
and vortexed to fully resuspend.  
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 We blanked the UV-VIS instrument with an empty cuvette for wavelengths from 
590- 610 nm. Then under the sterile field of a Bunsen burner, we prepared at least 0.6 L 
of WT cell suspension and 1.1 L of trk1Δtrk2Δ cell suspension with OD600 values between 
0.090-0.110. Next, 0.5 L of cell suspension was poured into a 0.5 L graduated cylinder to 
coat the inner surface. Then this cell suspension was poured back into the original bottle. 
Following, 0.5 L of cell suspension was measured and then transferred into sterile 0.5 L 
Erlenmeyer flasks for the WT and for the trk1Δtrk2Δ strains (two separate flasks). 
Serological pipettes were used to remove 12.5 mL of cell suspension from each flask. 
Afterwards, 12.5 mL of DMSO or small molecule solution was added to each Erlenmeyer 
flask, and we made sure to pipette up and down several times. We measured out 0.1 L 
for each treatment group (WT + DMSO, trk1Δtrk2Δ + DMSO, and trk1Δtrk2Δ + small 
molecule) and poured these cell suspensions into labeled 0.25 L Erlenmeyer flasks for 
the 6, 12, and 24 hour time points. The order by which the cell strains and flasks 
designated for each time point were measured out and treated with small molecule, was 
varied from experiment to experiment to avoid bias.  
 The remaining 200 mL of cell suspension (for the 0 hour timepoint) was rapidly 
filtered onto 0.8 μm filters, and washed with 100 mL each of ice cold 20 mM MgCl2 before 




 For the dose-response studies, we utilized the unpaired t-test for the DMSO 
controls and one-way ANOVA for the trk1Δtrk2Δ treatment groups. For the time-course 




Chemical Inhibition and Statistical Analysis 
 
We followed the same protocol as described previously for the overnight culturing 
conditions. For the chemical inhibition studies, at least 25 mL of a 5 μM AmB solution was 
prepared. The ratio of AmB to cell suspension was 1:50 (where 2 mL of AmB solution 
was added per 100 mL of cell suspension) and the ratio of inhibitor to cell suspension 
was 1:200 (where 0.5 mL of inhibitor solution was added per 100 mL of cell suspension). 
For Bafilomycin solutions, 1 mg of Bafilomycin B1 (Santa Cruz Biotechnology, sc-202072) 
was dissolved in 0.5 mL of DMSO to obtain a concentration of 2450.98 μM. Then 3 mL of 
a 100 μM stock solution was prepared in DMSO. Next, the following dilutions were 
prepared in DMSO: 
Table 4: Bafilomycin B1 Dilution 
Initial Concentration (μM) 0 12.5 25 50 100 
Final Concentration (μM) 0 0.0625 0.125 0.25 0.5 















Amount of DMSO to Add 
(0.5 mL 
per flask) 1.5 mL 1.5 mL 1.5 mL 0 
 
 For Ebselen, 5 mg of Ebselen (Cayman Chemical, 70530) were dissolved into 0.5 
mL of DMSO. The resulting 36.46 mM Ebselen solution was further diluted in DMSO to 
generate 3.5 mL of a 5000 μM solution. Then the following solutions were prepared 






 Table 5: Ebselen Dilution 
 
 The cells were harvested, washed, and resuspended in 15 mM KCl YNB, pH 5.8 
medium as previously described. This time, we obtained 0.7 L of WT and 0.9 L of 
trk1Δtrk2Δ cell suspensions with OD600 values between 0.090-0.110. Next, we measured 
out 0.5 L of WT cell suspension using a graduated cylinder to coat the inner surface. This 
cell suspension was poured back into the original 1 L bottle. Then 0.5 L of WT cell 
suspension was remeasured and then transferred to a sterile 0.5 L Erlenmeyer flask. 
Additionally, 0.1 L of WT cell suspension was obtained and transferred to a 0.25 L 
Erlenmeyer flask (this sample was designated for the WT + DMSO control). The same 
was done for the trk1Δtrk2Δ cells. We also included two additional controls for the 24 hour 
time points: trk1Δtrk2Δ + DMSO and trk1Δtrk2Δ + 100 nM AmB.  
Then 2.5 mL of cell suspension was removed from each flask designated for 
DMSO, 2 mL of cell suspension was removed from the 0.1 L flasks designated for AmB 
treatment, and 10 mL of cell suspension was removed from the 0.5 L flasks designated 
for AmB treatment. Next, 2.5 mL of DMSO was added to flasks designated for DMSO 
treatment. 2 mL of AmB was added to the 0.1 L flasks designated for AmB treatment. 10 
mL of 5 μM AmB was added to the 0.5 L flasks meant for AmB treatment.  
Following, we transferred the AmB treated cell suspensions to clean 1 L bottles 
and gently swirled to ensure homogenous mixing of the AmB solution. We measured out 
Initial Concentration (μM) 0 312.5 625 1250 2500 
Final Concentration (μM) 0 1.56 3.125 6.25 12.5 













Amount of DMSO to Add 
(0.5 mL 
per flask) 1.5 mL 1.5 mL 1.5 mL 1.5 mL 
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0.1 L of both AmB treated WT and trk1Δtrk2Δ cell suspensions and placed them into 
designated 0.25 L Erlenmeyer flasks. Then 0.5 mL of cell suspension was removed from 
each flask using serological pipettes. Afterwards, 0.5 mL of DMSO or chemical inhibitor 
was added to each flask in the indicated doses. The cell suspension was pipetted up and 
down several times to ensure full dispensing of the indicated chemical inhibitor solution. 
The flasks were cultured at 200 X RPM, 30°C, for 12 hours. We also had prepared 
trk1Δtrk2Δ + DMSO, and trk1Δtrk2Δ + AmB samples for the 24 hour controls. 
Table 6: Chemical Inhibition Treatment Groups. 
Flask 
Number Treatment Group Time Point (Hours) 
1 WT + DMSO 12 
2 WT + 100 nM AmB 12 
3 WT + 100 nM AmB + Dose 1 12 
4 WT + 100 nM AmB + Dose 2 12 
5 WT + 100 nM AmB + Dose 3 12 
6 WT + 100 nM AmB + Dose 4 12 
7 trk1Δtrk2Δ + DMSO 12 
8 trk1Δtrk2Δ + 100 nM AmB 12 
9 trk1Δtrk2Δ + 100 nM AmB + Dose 1 12 
10 trk1Δtrk2Δ + 100 nM AmB + Dose 2 12 
11 trk1Δtrk2Δ + 100 nM AmB + Dose 3 12 
12 trk1Δtrk2Δ + 100 nM AmB + Dose 4 12 
13 trk1Δtrk2Δ + DMSO 24 




 For chemical inhibition studies, we used the unpaired t-test to compare treatment 
groups. 
 
Determination of Ion Content by Inductively Coupled Plasma- Mass Spectrometry  
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 For both the dose-response and time-course studies, a 1 mL aliquot of sample was 
taken and reserved for absorbance (OD600) measurements by UV-VIS spectroscopy. 
Following, each 100 mL sample was rapidly filtered through a 0.8 μm membrane filter 
(EMD Millipore, catalog number AAWP04700) and washed with 50 mL of ice cold 20 mM 
MgCl2. Then the sample filter membranes were carefully transferred into clean 6 well 
plates, where each filter membrane was resuspended in 5 mL of ice cold 20 mM MgCl2 
to collect the cell suspension. Each of these cell suspensions were then transferred into 
clean and labeled 15 mL conical tubes. Afterwards, the samples were flash frozen in liquid 
nitrogen and lyophilized for at least 72 hours. Importantly, after 48 hours of lyophilization, 
the samples were gently agitated to ensure full removal of water from the samples and 
re-lyophilized for the remaining 24 hours. These samples were highly hygroscopic and 
care was taken to avoid exposure to water. 
 For best practice, the lyophilized samples were transferred into an argon glovebox. 
Five cycles of purging the antechamber with argon and then applying vacuum for 5 min. 
each were performed. Next, each sample was packed into aluminum capsules (provided 
by The UIUC Microanalysis Lab, with 1 – 10 mg of sample per capsule) and crimped shut 
with tweezers. The remaining sample was transferred into labeled 7 mL glass vials. The 
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CHAPTER 4: SMALL MOLECULE ION CHANNELS FUNCTIONALLY INTERFACE 





 Across all kingdoms of life, organisms possess robust mechanisms1,2,3,4,5 that 
enable them to respond and adapt to genomic and environmental perturbations.6 For 
example, a recent study found that humans on average harbor 20 genes that are 
completely inactivated; yet, these individuals show no phenotypic consequence.7 The 
specific molecular mechanisms of robustness include functional redundancy,8,9,10,11 
feedback control,12 parallel signaling,13 and modularity.8 
Briefly, functional redundancy occurs through gene duplication (more than one 
copy of a gene carries out the same biological process) and degeneracy (unrelated genes 
perform similar functions).14,15 In feedback control, positive or negative feedback signals 
can enhance sensitivity or reduce noise respectively.12 Parallel signaling allows for 
multiple pathways to converge onto a similar output.16 For example, in many metabolic 
pathways, intermediates can quickly be diverted and funneled into parallel reactions, to 
achieve the desired products. Last, modularity or compartmentalization, stops potential 
defects from infiltrating other parts of the cell or organism.8 
 However, when an organism is missing a protein that is critical for carrying out a 
vital cellular process, that organism’s functional capacity dips below the threshold 
required for normal physiology and results in a disease phenotype such as the lack of cell 
growth or disease (Figure 26, middle bar). Yet, we hypothesized that a residual level of 
functional capacity remains. We predicted that an imperfect small molecule mimic of the 
missing protein could functionally interface with the organism’s own robustness 
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mechanisms, and thereby provide enough functional capacity to enable the organism to 
regain normal physiology (Figure 26, right bar).  
 
Figure 26. Model of Small Molecule Mediated Functional Complementation. Wild 
type organisms (left bar) have many mechanisms of robustness such as functional 
redundancy, parallel signaling, feedback control, and modularity that enable them to 
survive and propagate despite environmental and genetic challenges. However, when the 
organism is missing a key protein (middle bar), the organism’s functional capacity drops 
below the threshold needed for normal physiology. Several robust mechanisms remain 
(middle bar). Functionally interfacing with the organism’s own robustness networks, a 
small molecule is hypothesized to provide the functional capacity necessary to enable the 
organism to regain normal physiology (right bar).  
 
 
 Excitingly, we discovered that imperfect small molecule mimics are sufficient to 
restore physiology in cellular systems and organisms ranging from yeast, to human lung 
epithelia, to vertebrates. For example, Hinokitiol (Hino.), a cedar tree derived tropolone 
natural product, binds to iron in a 3:1 ratio of Hino. to iron.17 We found that this small 
molecule carrier binds and transports iron across cellular membranes, by leveraging built-
up electrochemical gradients to restore physiology.17 Interestingly, Hino. was also found 
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to functionally interface with the cells’ inherent network of proteins involved in iron 
homeostasis including ferritin (sequesters iron) and ferroportin (releases excess iron).17 
In a completely different system, we discovered that an imperfect small molecule 
ion channel Amphotericin B (AmB) could restore physiology in a potassium (K+) 
transporter deficient (trk1Δtrk2Δ) yeast.18 We hypothesized that the interface between 
endogenous protein networks and small molecules could be broadly applicable. We 
sought to understand the endogenous proteins involved in promoting small molecule ion 
channel mediated rescue and utilized yeast as an outstanding eukaryotic model 
organism.  
 Ion homeostasis is vital for normal physiology.19,20,21 As in human cells, exquisitely 
regulated networks of protein ion pumps and cotransporters control the passage of ions 
across yeast membranes.22 Yeast express ATP driven H+ pumps V-ATPase and Pma1, 
which localize to the vacuolar and plasma membranes respectively (Figure 27). V-
ATPase and Pma1 hydrolyze ATP to force H+ into vacuoles and out of the cell 
respectively, leading to the acidification of vacuoles,23 establishment of intracellular 
pH,24,25,26 and production of favorable electrochemical gradients.23,27,28 These gradients 
power K+ flux through two K+ transporters, Trk1 and Trk223,27,29,30 and into vacuoles.23 
Yeast rigorously regulate intracellular K+ and sodium (Na+) concentrations to enable 
survival amidst varying extracellular K+ concentrations (2 μM to 2 M)31 and to avoid Na+ 
toxicity.23,32 Healthy cytoplasmic concentrations range from 200-300 mM19 for K+ and 10-
20 mM for Na+.33 Yeast do not express a selective Na+ transporter,23 and intracellular Na+ 




Figure 27. Yeast Possess Highly Regulated and Integrated Networks of Protein Ion 
Pumps and Transporters. H+ ATPases Pma1 (found on the plasma membrane) and V-
ATPase (localized to the vacuolar membrane) utilize the energy from ATP hydrolysis to 
establish electrochemical gradients across these membranes. Other protein transporters 
including Trk K+ transporters harness these gradients and import K+ through secondary 
active transport. Yeast also express K+ and Na+ exporters including voltage gated K+ 




 V-ATPase and Pma1 are widely accepted as the primary H+-ATPases in charge 
of producing electrochemical gradients. V-ATPase is a hetero-multimeric protein with two 
distinct structural components V0 (H+ passageway) and V1 (active site for ATP 
hydrolysis).26,34 V-ATPase is regulated by low glucose, where domains Vo and V1 
reversibly separate.26 K+ starvation triggers P2-type ATPase35 Pma1 to ramp up its 
activity, but not its protein expression.36 Trk1Δtrk2Δ cells deprived of K+ significantly 
increase Pma1 activity relative to that in WT.36 Furthermore, truncation of Pma1 prohibits 
cell growth under low K+ conditions (1 mM K+).36 
 Yeast also express plasma membrane localized voltage gated K+ efflux channel 
Tok1,37,38 Na+(K+)/(H+) anti-porter Nha1,39,40,41 and Na+-ATPase Ena1-5,42 all of which 
play an important role in releasing Na+ and/or K+ to maintain ion homeostasis43 (Figure 
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27). For its regulation, Tok1 is an eight-transmembrane domain channel that responds to 
depolarization of the plasma membrane.27 Nha1 possesses 12 transmembrane domains, 
is constitutively expressed, and functions under acidic conditions.27 Last, cells express 
low levels of Ena1-5 where each protein contains 10 transmembrane domains.44 
However, cells show increased expression of Ena1-5 upon exposure to basic pH, 
perturbations in osmotic pressure, salt stress, and lack of glucose.27   
 Since AmB small molecule ion channels conduct both K+ and Na+, we 
hypothesized that Tok1, Nha1, and/or Ena1-5 are critical for AmB mediated ion channel 
rescue, by expelling excess Na+ and/or K+ ions (Figure 28B). Through both 
pharmacological and genetic approaches, we tested the hypothesis that protein drivers 
(V-ATPase and Pma1, Figure 28A) and protein correctors (Tok1, Nha1, and Ena1-5, 
Figure 28B) are critical for small molecule mediated rescue of trk1Δtrk2Δ growth. 
Furthermore, we expanded this study to investigate other potential proteins that 
functionally interface with small molecule mimics through performing DNA microarray 
analysis.  
 
Figure 28. Protein Drivers and Correctors Functionally Interface with Small 
Molecule Mimics to Restore Physiology. A. Protein drivers Pma1 and V-ATPase  
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Figure 28. (continued) 
generate favorable electrochemical gradients to mediate cation influx through imperfect 
small molecule ion channels. B. Protein correctors Tok1, Nha1, and Ena1-5 are predicted 
to address the lack of ion selectivity of small molecule ion channels, through expelling 




First, we questioned whether Pma1 and V-ATPase enable imperfect small 
molecule ion channel mimics to rescue cell growth in trk1Δtrk2Δ yeast. We hypothesized 
that chemical inhibition of Pma1 and V-ATPase activity would impair small molecule 
mediated restoration of cell growth, i.e. small molecule ion channel rescued cells would 
show increased sensitivity to inhibition of Pma1 and V-ATPase compared to that of WT 
cells. To test this hypothesis, we employed three inhibitors (Figure 29): Nocodazole 
(impedes microtubule dynamics, negative control),45,46 Ebselen (inhibits Pma1),47 and 
Bafilomycin (blocks V-ATPase).48 We tested these inhibitors against WT and trk1Δtrk2Δ 
cells treated with small molecule ion channels and grown under standard K+ conditions 




Figure 29. Chemical Inhibition of Protein Drivers. Schematic showing the three targets 
of the chemical inhibition studies. Nocodazole inhibits microtubule dynamics and served 
as an off-target pathway inhibitor; microtubule dynamics are not predicted to be directly 
involved in small molecule mediated rescue. Ebselen and Bafilomycin inhibit Pma1 and 
V-ATPase respectively.  
 
 
Nocodazole impairs microtubule dynamics, a process unrelated to K+ transport and 
thus served as a negative control. We observed no statistically significant difference in 
the half maximal effective concentration (EC50) between chemical inhibition of WT versus 
trk1Δtrk2Δ + AmB (Figure 30A and Figure 30D; EC50 ± SEm: 24.8 μM ± 0.2 and 24.5 μM 
± 0.3, respectively). Similarly, Nocodazole inhibition of Nystatin (Nyst.)-, Candicidin 
(Can.)-, and Mepartricin (Mep.)-treated WT and rescued trk1Δtrk2Δ cells showed little to 
no statistically significant difference in sensitivity (Figure 30D). In contrast, we observed 
that AmB-rescued trk1Δtrk2Δ cells showed increased sensitivity to Ebselen compared to 
that of WT cells (Figure 30B and Figure 30E; EC50: 7.3 μM ± 0.2 and 13.2 μM ± 0.1 
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respectively, ****P). Similar results were obtained in Nyst.-, Can.-, and Mep.-rescued 
trk1Δtrk2Δ cells (Figure 30E). In addition, we noted exceptional sensitivity of AmB-
rescued trk1Δtrk2Δ cells compared to that of WT cells to Bafilomycin inhibition in Figure 
30C and Figure 30F (EC50: 0.05 μM ± 0.03 and 0.6 μM ± 0.01 respectively, ****P). Nyst.-
, Can.-, and Mep.-rescued trk1Δtrk2Δ cells also showed high sensitivity towards 
Bafilomycin compared to that of WT cells (Figure 30F). These results provide evidence 
that Pma1 and V-ATPase promote small molecule mediated rescue of trk1Δtrk2Δ growth. 
 
 
Figure 30. Chemical Inhibition of Small Molecule Mediated Rescue. A. Both WT + 
AmB and trk1Δtrk2Δ + AmB treatment groups responded similarly to Nocodazole 
inhibition. B. trk1Δtrk2Δ + AmB cells showed diminished cell growth at lower 
concentrations of Ebselen (blocks Pma1) than that observed in WT + AmB. C. Bafilomycin 
(inhibits V-ATPase) reduced cell growth of trk1Δtrk2Δ + AmB cells at lower concentrations 
compared to that of WT + AmB. D. AmB, Nyst., Can., and Mep. rescued trk1Δtrk2Δ cells 
were similarly affected by Nocodazole inhibition as AmB, Nyst., Can., and Mep. treated 
WT cells at 24 hours. E. Ebselen blocking of cell growth was achieved at lower 
concentrations in small molecule rescued trk1Δtrk2Δ cells compared to that of small 
molecule treated WT cells at 24 hours. F. Bafilomycin dramatically reduced small 
molecule rescue of trk1Δtrk2Δ cell growth compared to that of WT cells at 24 hours. WT 




The ion channel formed by AmB is unrectified, unregulated, and unselective 
(enables passive transport of K+, Na+, chloride (Cl-), and bicarbonate (HCO3-) ions).49,50 
We next questioned whether protein ion efflux channels and exchangers play a role in 
enabling tolerance for the lack of ion selectivity of small molecule ion channel mimics. 
Voltage gated K+ efflux channel Tok1, plasma membrane localized anti-porter Nha1 
(couples H+ influx for Na+/K+ efflux), and Na+-ATPase Ena1-5 play an important role in 
mediating Na+ and/or K+ efflux to maintain ion homeostasis. We hypothesized that Tok1, 
Nha1, and/or Ena1-5 may contribute to imperfect small molecule ion channel rescue 
through extruding excess Na+ and/or K+ ions. To test this hypothesis, we acquired a series 
of isogenic yeast strains lacking Trk1 and Trk2, Tok1, Nha1, Ena1-5, or their combination.  
 Under standard K+ conditions, we observed no differences in growth between WT 
and nha1Δ strains (Figure 31B). Consistent with previous results, AmB restored cell 
growth in trk1Δtrk2Δ cells.18 However upon deletion of Nha1, we observed no AmB 
mediated restoration of cell growth in trk1Δtrk2Δnha1Δ. This result was similarly observed 
for Nyst. (Figure 31E), Can. (Figure 31H), and Mep. (Figure 31K) treated cells. In 
contrast, deletion of either Tok1 or Ena1-5 did not affect AmB (Figure 31A and Figure 
31C), Nyst. (Figure 31D and Figure 31F), Can. (Figure 31G and Figure 31I), or Mep. 
(Figure 31J and Figure 31L) mediated rescue of cell growth in trk1Δtrk2Δtok1Δ and 
trk1Δtrk2Δena1-5Δ, respectively. Therefore, these results show that Nha1 is important 







Figure 31. Nha1 is Critical for Small Molecule Mediated Rescue. A. Deletion of 
voltage-gated, K+ efflux pump Tok1 did not impact AmB mediated rescue of growth in 
trk1Δtrk2Δtok1Δ. Furthermore, we did not observe differences in growth between WT and 
tok1Δ cells. B. In contrast, deletion of Na+/H+ antiporter, Nha1 impaired AmB mediated 
restoration of trk1Δtrk2Δnha1Δ growth, while loss of Nha1 alone did not have any  
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Figure 31. (continued) 
detrimental effects on cell growth. C. ATP-driven Na+ pumps, Ena1-5 are not required for 
AmB mediated rescue of trk1Δtrk2Δena1-5Δ. Similar trends were observed for Nyst., in 
D.–F. WT and trk1Δtrk2Δ values were replotted through graphs A.-F. for clarity. These 
experiments were performed under conditions of 15 mM KCl Yeast Nitrogen Base (YNB), 
pH 5.8, 200 X RPM, 30°C and absorbance values (OD600) were obtained at 72 hours. 
(Graphs represent the average of 2 independent experiments, with 3 biological replicates 
per experiment). Similar results were observed for Can. where rescue was observed for 
G. trk1Δtrk2Δtok1Δ, not for H. trk1Δtrk2Δnha1Δ, and growth was noted in I. 
trk1Δtrk2Δena1-5Δ. We observed the same trends for Mep. with J. trk1Δtrk2Δtok1Δ, K. 
trk1Δtrk2Δnha1Δ, and L. trk1Δtrk2Δena1-5Δ. Graphs G.-L. were performed in 10 mM KCl 
YNB, pH 5.8 and absorbance values (OD600) were obtained at 24 hours. The graphs 
depict the average of 2 independent experiments with 3 biological replicates per 
experiment (except for N = 5 total biological replicates for graph H.).  
 
 
 We next asked whether trk1Δtrk2Δ cells would undergo global transcriptional 
changes in response to K+ limitation. Previous reports show that yeast react to changes 
in extracellular K+ by altering gene expression.28 Trk1Δtrk2Δ cells decreased the 
expression of 79 genes and elevated transcript levels of 69 genes compared to that of 
WT in 50 mM K+ Yeast Nitrogen Base (YNB).28 We hypothesized that we would observe 
an even greater transcriptional response of trk1Δtrk2Δ cells subjected to an even more 
stringent K+ limitation of 10 mM KCl YNB and predicted that AmB mediated rescue would 
mitigate these transcriptional changes. Furthermore, through pursuing a global 
transcriptional analysis, this could possibly lead to the identification of other key proteins 
that functionally interface with small molecule mimics.  
To probe this question, we investigated the changes in gene expression by 
performing a DNA microarray analysis. First, we developed a large-scale rescue assay 
to obtain sufficient quantities of high-quality RNA suitable for DNA microarray analysis. 
We treated both WT and trk1Δtrk2Δ cells with and without AmB and collected samples at 
0 and 180 minutes. We chose this early time point to capture cells that are in the same 
77 
 
cell cycle stage. Importantly, we validated small molecule mediated rescue in these 
samples by measuring the growth of the trk1Δtrk2Δ + AmB cells at 24 hours (Figure 32).  
 
Figure 32. Large Volume Rescue Assay for DNA Microarray Analysis. The 
absorbance at 600 nm (OD600) was determined for each sample at 24 hours for 




 For the DNA microarray results, we generally observed similar expression profiles 
for WT + DMSO vs. WT + AmB at 0 minutes, WT + DMSO vs. WT + AmB at 180 minutes, 
and trk1Δtrk2Δ + DMSO vs. trk1Δtrk2Δ + AmB at 0 minutes (Figure 33). In contrast, we 
found marked differences in gene expression profiles for trk1Δtrk2Δ + DMSO vs. 
trk1Δtrk2Δ + AmB at 180 minutes. To identify candidate genes, we first generated a 
weighted gene co-expression network51,52,53 (WGCNA). The WGCNA reveals correlation 
networks among the genes investigated and yields “biologically relevant modules and 
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corresponding intramodular hubs,”52 wherein one would expect that per module, there 
would be an over-representation of genes involved in a similar biological process.  
 
 
Figure 33. DNA Microarray Analysis of AmB Rescued trk1Δtrk2Δ Cells at 0 and 180 
Minutes. 3910 genes with an analysis of variance (ANOVA) false discovery rate (FDR), 
p < 0.05 were analyzed of samples from N = 3-4 independent experiments.  
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Next, we clustered this network into 24 distinct modules,51 wherein the genes in 
each of these modules were highly related. We associated these modules with their gene 
ontology for biological process, molecular function, or cellular component. Afterwards, we 
performed a KME analysis (Figure 34). The kME indicates how well a specific gene fits 
within a module’s expression profile.54 Over 6256 genes were examined wherein the kME 
threshold was set at 0.8 and the -log(raw p-value) was set to 5 = 0.00001. This analysis 
yielded 73 genes or open reading frames (ORF) that displayed significantly increased or 
decreased expression in trk1Δtrk2Δ + AmB vs. trk1Δtrk2Δ + DMSO.  
 
Figure 34. kME Analysis of AmB Mediated Restoration of Physiology in trk1Δtrk2Δ 
Yeast. 6256 genes were investigated and a cut-off value was set, where -log(raw p-value) 
of 5 = 0.00001. 
 
 
 The kME analysis revealed both overexpressed Table 7 and under-expressed 
Table 8 genes in AmB rescued trk1Δtrk2Δ cells. These genes encode proteins with 
diverse functions including transport, enzyme activity, cell cycle, spore wall structure, and 
stress response. Intriguingly, SIT1 (ARN family transporter),55 AQR2 (cell surface 
transporter),56 and QDR2 (mono- and divalent cation transporter)57 were found to be 
greatly upregulated with fold changes of 5.2, 4, and 2.1 respectively (Table 7).  
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Table 7: kME Analysis Revealed Overexpressed Genes for AmB Rescued trk1Δtrk2Δ 
Cells. Genes involved in various biological processes are highlighted in different colors: 
transport (green), stress (purple), enzyme function (blue), other (black).58,59  
 
 In contrast, YGP1 (secretory glycoprotein),60 ADH2 (alcohol dehydrogenase),61 
and PHO84 (inorganic phosphate transporter)62 were all found to be downregulated with 
a fold change of -10.8, -5.4, and -5.0 respectively (Table 8). These findings warrant further 
investigation through validation with RT-qPCR, and knock-down and overexpression 
studies. In addition, investigating how these gene expression levels change over time and 
in response to reintroducing normal K+ levels may reveal insights into the contributing 
roles of these proteins.  
81 
 
Table 8: kME Analysis Showed Decreased Gene Expression in AmB Rescued 
trk1Δtrk2Δ Cells. Genes involved in various biological processes are highlighted in 
different colors: transport (green), stress (purple), enzyme function (blue), cell cycle 





 Next, we investigated the change in gene expression of our candidate proteins that 
we hypothesized would functionally interface with small molecules. DNA microarray 
analysis and subsequent RT-qPCR validation showed no significant changes in the gene 
expression of PMA1 (Figure 35A), V-ATPase subunit63 VPH1 (Figure 35B), TOK1 
(Figure 35C), NHA1 (Figure 35D), and ENA1 (Figure 35E) among treatment groups at 
180 min. These results demonstrate that AmB rescued trk1Δtrk2Δ cells may not 
transcriptionally regulate these genes at this early time point. The expression of these 
genes may change at later time points or the cells may instead regulate the activity of the 
corresponding proteins.  
 
Figure 35. Real Time Quantitative Polymerase Chain Reaction Analysis of 
Candidate Genes. RT-qPCR analysis was performed to determine A. PMA1, B. VPH1 
(subunit of V-ATPase), C. TOK1, D. NHA1, E. ENA1 gene expression levels. Solid bars 
represent 0 minutes and patterned bars indicate 180 minutes of treatment, N = 3 






 We demonstrated through pharmacological and genetic approaches that 
endogenous protein pumps (drivers, V-ATPase and Pma1) and protein correctors (Nha1) 
functionally interface with imperfect small molecule mimics to restore physiology. Loss of 
activity through chemical inhibition and loss of function through genetic deletion abrogates 
small molecule mediated rescue of cell growth. These studies show that small molecule 
surrogates can interface with cellular homeostatic mechanisms for ion movement. These 
findings also suggest the broad utility of small molecule surrogates in diverse eukaryotic 
systems, through working in concert with highly conserved mechanisms of ion 
homeostasis. 
 Intriguingly, loss of Nha1 by gene knockout completely abolished small molecule 
mediated rescue. Nha1 is known to extrude excess Na+ ions under acidic conditions. We 
hypothesize that Na+ enters cells through unselective small molecule ion channels. In 
cells missing Nha1, Na+ ions may accumulate to toxic levels. To elucidate this hypothesis, 
we intend to quantify the change in total cellular Na+ content in small molecule treated 
trk1Δtrk2Δnha1Δ cells.  
 No significant changes in gene expression were observed for PMA1, VPH1, TOK1, 
nor NHA1. These proteins may either be constitutively expressed or their activity is 
regulated. We were surprised to observe no change in ENA1-5 expression. Literature 
reports describe an increase in expression of ENA1-5 upon exposure to salt stress and 
alterations in osmotic pressure.27 Three hours may potentially be insufficient to induce a 
change in ENA1-5 gene expression, as the small molecule rescued trk1Δtrk2Δ cells may 
still exist in lag phase. Investigation of later time points including 6 and 12 hours may 
84 
 
reveal greater changes in gene expression as small molecule rescued trk1Δtrk2Δ cells 
demonstrate entry into the exponential phase.  
 Future studies will focus on the candidate genes found to be increased (Table 7) 
or decreased (Table 8) in expression. In addition, we are interested in investigating 
whether other small molecule ion channels also induce similar changes in the expression 




 Jenn Hou performed the chemical inhibition studies (Figure 30), conducted the 
liquid broth dilution assays for the isogenic mutant strains (Figure 31), developed and 
executed the large scale rescue assays (Figure 32), isolated RNA and prepared cDNA 
samples for DNA microarray analysis, and ran the RT-qPCR assays for the candidate 
genes (Figure 35). Dr. Jenny Drnevich of The Roy J. Carver Biotechnology Center at 
UIUC designed the DNA microarray assay, performed the DNA microarray data analysis 
(Figure 33), and conducted the WGCNA and kME analyses. Mary Majewski of The 
Edward R. Madigan Lab at UIUC, performed the BioAnalyzer quality analysis for all cDNA 
samples and ran the DNA microarray.  
 




 Isogenic yeast strains BY4741 (WT), BYT3 (tok1Δ), BYT4 (nha1Δ), BYT5 (ena1-
5Δ), BYT12 (trk1Δtrk2Δ), BYT123 (trk1Δtrk2Δtok1Δ), BYT124 (trk1Δtrk2Δnha1Δ), and 
BYT125 (trk1Δtrk2Δena1-5Δ) were kindly gifted by Dr. Joaquín Ariño from The Universitat 
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Autònoma de Barcelona and Dr. Hana Sychrová from The Academy of Sciences of the 
Czech Republic. 
 
Chemical Inhibition Assay 
 Before conducting the experiment, we suspended 3-5 colonies each of wild-type 
Saccharomyces cerevisiae (S. cerevisiae, ATCC9763) and of trk1∆trk2∆ S. cerevisiae 
(SGY1528) in 100 mM KCl supplemented YPAD pH 5.0 medium, and cultured overnight 
at 30°C and speed 200 X RPM for 14 to 18 hours. Prior to harvesting the cells, small 
molecules (AmB, HPLC purified AKScientific), Nyst. (Riedel-de-Haen), Can. (TOKU-E), 
or Mep. (Santa Cruz Biotechnology) and chemical inhibitors Nocodazole (Sigma Aldrich), 
Ebselen (Cayman Chemical), and Bafilomycin B1 (Santa Cruz Biotechnology) stock 
solutions were prepared in DMSO. The chemical inhibitor working solutions comprise a 
range of incremental concentrations.  
 After 14-18 hours of cell culture, we centrifuged 20 mL of cells at 1000 X G for 5 
min. at 23°C. The supernatant was decanted, then the cells were resuspended in 20 ml 
of sterile milliQ H2O per cell pellet (cell pellet was vortexed until fully dispersed). Next, the 
cells were centrifuged at 1000 X G for 5 min at 23°C. The wash step was repeated.  
 Following, we decanted the supernatant and resuspended the cells in YPAD pH 
5.0 medium (with no K+ added). Then we diluted both WT and trk1∆trk2∆ samples in 
YPAD pH 5.0 medium (with no K+ added) to an OD600 value between 0.095 and 0.105 
after allowing the samples to stabilize after 5 min. Afterwards, both WT and trk1∆trk2∆ 
cells with OD600 values between 0.095 and 0.105 were diluted 10-fold in YPAD, pH 5.0 
medium (no K+ added). To these diluted cell suspensions, the appropriate amount of 
AmB, Nyst., Can., or Mep. were added to give final rescuing concentration of (125 nM, 1 
86 
 
μM, 8 nM, and 8 nM respectively). A control was prepared by adding the corresponding 
volume of DMSO vehicle to the trk1∆trk2∆ cell suspension, to check for contamination. 
 Under a sterile field, 195 μL of WT + small molecule, 195 μL of trk1∆trk2∆ + small 
molecule, and 195 μL of trk1∆trk2∆ + DMSO were added to the appropriate wells. Next, 
5 μL of DMSO or chemical inhibitor was added to each well, with each concentration 
tested in triplicate for both WT and trk1∆trk2∆ treatment groups. The 96 well plate was 
gently rotated several times before placing into the 30°C incubator. After 24 hours, all 
wells were gently resuspended before obtaining a plate reader (BioTek Synergy H1) 
absorbance measurement at 600 nm.  
 
EC50 Determination and Statistical Analysis of Chemical Inhibition 
 Utilizing GraphPad PRISM, we fitted the data (nonlinear regression, inhibition dose 
response, variable slope (four parameters)) to yield IC50 values with SEm. For statistical 
analysis of the IC50 values, we compared the two treatment groups with the unpaired t-
test.  
 
Small Molecule Treatment of Mutant Tok1, Nha1, and Ena1-5 Yeast Strains  
The following experiments were performed under sterile conditions. Five single 
colonies of each yeast strain were resuspended into 1 mL of 100 mM KCl YPD medium 
and then this 1 mL cell suspension was added to 100 mL of 100 mM KCl YPD medium. 
The cultures were grown overnight at 200 X RPM, 30°C for 12 - 24 hours until fully 
saturated. Next, approx. 25 mL of each cell suspension was centrifuged at 1000 X G for 
5 min, at 23°C. The supernatant was removed and the cells were resuspended in 25 mL 
of sterile Milli-Q H2O. Afterwards, the cells were vortexed to fully re-suspend them and 
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then re-centrifuged. This step was repeated once more. Following, the cells were 
resuspended in 15 mM KCl YNB pH 5.8 medium (for AmB and Nyst. studies) or in 10 mM 
KCl YNB pH 5.8 (for Can. and Mep. studies). Under the sterile field of the Bunsen burner, 
the cells were diluted in either 10 mM or 15 mM KCl YNB pH 5.8 medium to OD600 values 
between 0.090-0.110. 195 μL of cell suspension was pipetted into 96 well plates and 
dosed with 5 μL of DMSO or each corresponding small molecule (AmB, Nyst., Can., and 
Mep., as described above) to give the indicated final concentrations, in triplicate. The 
plates were incubated at 30°C for either 24 hours (for Can. and Mep. studies) or 72 hours 
(for AmB and Nyst. studies, at 200 X RPM), protected from light. Absorbance values were 
determined at 600 nm on a BioTek plate reader. 
 
Large Scale Rescue Assays for Gene Expression Analysis 
 Isogenic BY4741 (WT) and BYT12 (trk1Δtrk2Δ) yeast were streaked onto 100 mM 
KCl supplemented YPD agar plates and incubated for at least 48 hours at 30°C. The 
plates were kept upside down during this time to avoid dispersing the single colonies, due 
to condensation. To prepare starter cultures, one single colony was pipetted per culture 
tube of 4 mL of 100 mM KCl YNB pH 5.8. At least three separate tubes of each strain 
were prepared.  
 We checked the optical density (OD600) of the starter cultures by UV-VIS. When 
the cultures were saturated with an OD600>1, we then transferred 3 mL of cell suspension 
to 52 mL each of 100 mM KCl supplemented YNB pH 5.8. We incubated the cells at 200 
X RPM, 30°C. The OD600 was monitored by UV-VIS and the cells were harvested during 
exponential phase with OD600 values ranging from 0.6-0.8. 
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 A fresh stock solution of AmB was prepared by dissolving a small amount in 
DMSO. A gas tight syringe was used to measure out 1.998 mL of methanol (MeOH) to 
three separate glass vials. Then 2 μL of AmB was added per vial to dilute 1:1000. Next, 
we blanked the UV-VIS with MeOH and determined the absorbance at 406 nm. The 
concentration was determined by applying the Beer-Lambert Law with ε = 164,000M-1cm-
1. Following, 7 mL of a 5 μM stock was prepared in DMSO.  
 We harvested 50 mL of each cell strain by centrifuging at 1000 X G, 23°C for 5 
min. Following, we removed the supernatant and then resuspended the cells in 50 mL 
each of sterile milli-Q H2O. Afterwards, we vortexed the cells at speed 10, with 5 pulses 
each. Next, we centrifuged the cells. We performed the wash step once more.  
 Once the cells were washed, we resuspended the cells in 7.5 mL each of 10 mM 
KCl YNB pH 5.8 and gently swirled each conical tube. Then we vortexed the cell 
suspensions. We utilized the UV-VIS to dilute each cell strain in 10 mM KCl YNB pH 5.8 
to achieve an OD600 between 0.090-0.110 with a total volume of 250 mL for each strain. 
Afterwards, we measured 125 mL of each cell suspension using clean graduated 
cylinders and transferred these cell suspensions into labeled 500 mL Erlenmeyer flasks. 
 Next, we carefully removed 3.125 mL of cell suspension from each flask and added 
3.125 mL of 5 μM AmB to all AmB labeled flasks. DMSO was added to the respective 
DMSO labeled flasks. We tested the following treatment groups of WT + DMSO, WT + 
AmB, trk1Δtrk2Δ + DMSO, and trk1Δtrk2Δ + AmB. Across all four independent 
experiments, we made sure to vary the order in which each compound was added, and 
the order in which the strains were harvested to avoid batch effects. We used a clean 
serological pipette for each addition, and made sure to pipette up and down several times 
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to fully dispense the DMSO or AmB solutions. Then we withdrew 90 mL of treated cell 
suspension from each flask and transferred this into chilled, labeled conical tubes, with 
30 mL of cell suspension per conical tube; the tubes were kept on ice. We centrifuged the 
samples at 3000 X G, 5 min, 4°C. During this time, we transferred the flasks into the 
shaking incubator and cultured at 200 X RPM, 30°C.   
 For the centrifuged samples, the supernatant was carefully removed from the small 
cell pellets. The respective cell pellets were combined and we filled the conical tubes with 
cold 1 X PBS (45 mL maximum). We gently inverted each tube 3X (no vortexing) and 
centrifuged at 3000 X G, 5 min, 4°C. We carefully removed the supernatant by tilting each 
conical tube to the side and then aspirating off any fluid. We then proceeded to isolate 
RNA.  
The same procedure described was performed for the 3 hour time point, except 
only 25 mL of treated cells were harvested, and 20 mL of ice cold 1 X PBS was used to 
wash.  
 
RNA Isolation  
 
 This protocol was performed following the Qiagen’s RNeasy Kit instructions.64 We 
describe the company’s protocol here. All surfaces, the microcentrifuge, and pipettors 
were sprayed with RNAse Zap. We carefully added 100 μL of Y1 buffer per pellet (1 mL 
Qiagen Y1 buffer with a speck of lyticase, and 1.60 μL of β-mercaptoethanol) and 
incubated at 30°C, 200 X RPM, for 30 minutes. We prepared buffer RLT ahead of time 
by adding 10 μL of β-mercaptoethanol per 1 mL of buffer RLT. DNAse I was also prepared 
by adding 350 μL of buffer RDD per 50 μL of DNAse I stock. After the 30 minute lyticase 
incubation was complete, we carefully added 350 μL of buffer RLT per conical tube and 
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vortexed at maximum speed for 10 seconds. Then we vortexed each sample for an 
additional 5 seconds. Next, we added 250 μL of 100% EtOH per sample and gently 
pipetted up and down 10 times. We transferred this solution to labeled spin columns. We 
centrifuged the samples at 10,000 X RPM, for 30 seconds, at 23°C. Then we removed 
the flow through. Afterwards, we added 350 μL of buffer RWI and centrifuged at 10,000 
X RPM, 23°C, for 30 seconds. Afterwards, we removed the flow through. Next, we added 
80 μL of DNAse I directly to the column and let this sit for 15 minutes at room temperature.  
 Next, we added 350 μL of buffer RWI and centrifuged at 10,000 X RPM, 23°C, for 
30 seconds. We removed the flow through. Then we added 500 μL of buffer RPE and let 
the tubes sit for 5 minutes. We made sure to coat the inner surfaces. Then we centrifuged 
at 10,000 X RPM, 23°C, for 30 seconds. We removed the flow through. Following we 
added 500 μL of buffer RPE per spin column and centrifuged at 10,000 X RPM, 23°C, for 
2 minutes. We removed the flow through. 
 We transferred the spin columns to new collection tubes and centrifuged at 10,000 
X RPM, 23°C, for 1 minute. We removed the collection tubes and transferred the spin 
columns to newly labeled, RNAse free Eppendorf tubes. We added 20 μL of RNase free 
H2O and let this sit for 5 minutes. Then we centrifuged at 10000 X RPM, 23°C, for 1 
minute. We repeated the RNase free H2O step once more. We kept a small 2.5 μL aliquot 
for NanoDrop concentration measurement. We stored the rest of the RNA samples in 
labeled tubes and kept the samples at -80°C. We repeated these steps for the 180 minute 
samples but modified the following steps including that we only collected 25 mL of cell 
suspension, and we only used 20 mL of ice cold 1 X PBS to wash. All samples 




Bioanalyzer Analysis and DNA Microarray Sample Submission 
 
 We first determined the concentration of the RNA samples by NanoDrop. Then we 
diluted the samples in DEPC treated H2O to obtain concentrations around 250 ng/μL. We 
aliquoted 3 μL of each treatment group for the Bioanalyzer analysis and 4 μL of each 
treatment group for the DNA Microarray analysis. The samples were kept at -80°C until 
they were ready to submit to the Roy J. Carver Biotechnology Center. Bioanalyzer 
analysis showed that all samples had an RNA integrity number (RIN) > 9.0. 
 
cDNA Synthesis 
 We followed the manufacturer’s instructions for the Superscipt VILO.65 All surfaces 
were cleaned with RNAse Zap. First, VILO reaction mix and 10X superscript enzyme were 
added as instructed. Then 2500 ng of RNA per sample was added per respective tube. 
Following, the reaction mixtures were added to RNAse free strip tubes and incubated at 
25°C for 10 minutes, 42°C for 90 minutes and 85°C for 5 minutes. After the reactions 
were completed, we transferred the cDNA to labeled tubes and stored them at -80°C. 
 
Real Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
 
 The following protocol was adapted from Taqman Gene Expression Assays.66 We 
utilized RNAse free tubes and RT-qPCR Grade H2O. Per tube, we added 25 μL of 
nuclease free H2O, 20 μL of cDNA template, and 55 μL of probe master mix. For the 
master mix, we added per probe 47 μL of gene expression assay and 470 μL of Taqman 
Gene Expression mix. Then we carefully pipetted 20 μL per well. We also prepared no 
template controls by adding 20 μL of nuclease free H2O instead of cDNA template. We 
gently covered the plate with a PCR adhesive film, vortexed the plate briefly, and then 
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centrifuged at 1000 X RPM for 1 minute, at 23°C. Then we setup the RT-qPCR instrument 
to run at 50°C for 2 minutes, 95°C for 10 minutes, and then 40 cycles of 95°C for 15 
seconds and 60°C for 1 minute. To assess for statistical significance, we analyzed the 
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 Polyene macrolides represent a diverse and chemically complex group of natural 
products,1 with several universal structural features including a core macrocyclic ring, 
polyene region of varying lengths, and mycosamine sugar appendage.2 Since the initial 
isolation of Nystatin (Nyst., 1950),3 Rimocidin (1951),4 and Trichomycin (1952),5 the field 
of polyene natural products has continued to capture immense attention. The study of 
polyene macrolides has not only unveiled insights into the polyketide synthase (PKS) 
machinery,6,7 but has also demonstrated their utility as broad spectrum antifungal agents.8 
For example, for more than 60 years Amphotericin B (AmB) has served as a potent 
antifungal agent for the treatment of systemic and life-threatening infections without the 
emergence of resistance.9,10 However, one major limitation of AmB is its dose-limiting 
toxicity,11 which precludes its use at high concentrations.  
 Previously, The Burke Group found that AmB primarily exerts its antifungal activity 
via sterol binding and extraction, contrary to the widely accepted mechanism of ion 
channel formation.12 With this key finding in hand, current synthetic efforts are heavily 
geared towards the generation of less toxic AmB derivatives that preferentially bind 
ergosterol (primary sterol in yeast) over cholesterol (primary sterol in mammals),13 while 
retaining efficacy against a broad spectrum of pathogenic yeast and avoiding the 
development of resistance. 
This mechanistic discovery enabled the distinction of AmB’s ion channel activity 
from its cell killing activity; wherein use of this small molecule at low concentrations favors 
ion channel formation.12 Through repurposing AmB as an imperfect small molecule ion 
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channel mimic, we found that this small molecule surrogate was sufficient to restore 
physiology in protein ion channel deficient yeast14 and in cystic fibrosis transmembrane 
conductance regulator (CFTR) deficient human lung epithelia.15 
 In this vein, we are invested in identifying novel polyene macrolides for their 
potential use as antifungal agents or as therapies for protein ion channel deficiencies. 
Structural comparison of at least 30 reported polyene macrolides2 and their variants 
demonstrates a high degree of conservation of the hemiketal region and mycosamine 
appendage (Figure 36,16 shaded region). We hypothesized that an in-depth biosynthetic 
gene cluster analysis of several highly conserved domains and/or enzymes, taken in the 
context of neighboring genomic regions, in Streptomyces and related genus members 
could yield potentially uncharacterized producing organisms of polyene macrolides.  
To probe this hypothesis, we teamed up with Professor Doug Mitchell and his 
group at UIUC. They are leaders in the field of biosynthetic gene cluster (BCG) analysis 
and natural product discovery. The Mitchell Group created a powerful and user-friendly 
biosynthetic gene cluster analysis program called RODEO (Rapid ORF Description and 
Evaluation Online).17 RODEO was highly successful in identifying previously 
uncharacterized lasso peptides.17 We predicted that RODEO analysis of mycopolyene 
BCGs from Streptomyces18 and related species, taken together with Prediction 
Informatics for Secondary Metabolomes (PRISM) analysis would reveal previously 
uncharacterized polyene macrolides. With these potential targets and our established 
disc diffusion assay, we could thus effectively screen bacterial extracts predicted to 
contain uncharacterized polyene macrolides, and evaluate them for their antifungal and/or 









Figure 36. Conserved Structural Region of Polyene Macrolide Natural Products.16 
Like protein sequences, we analyzed the structural sequences of at least 30 polyene  
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Figure 36. (continued) 
macrolides. The hemiketal and mycosamine appendage were found to be highly 
conserved. [This analysis was performed by and this figure was reproduced from Dailey, 
I. (June 6, 2012). Synthesis and function of the conserved motif of mycosamine-
containing polyene macrolides. Retrieved from Graduate Dissertations and Theses at 
Illinois (http://hdl.handle.net/2142/95658)].  
 
 
RODEO and PRISM analyses and the identification of novel polyene macrolides 
will also enable the characterization of the relationship between polyene length and ion 
channel activity.19 Literature reports,20 as well as our own studies suggest that the length 
of the polyene region influences the capacity of these small molecules to form ion 
channels. For example, Natamycin (Nat., a tetraene) effectively binds sterols but does 
not permeabilize cells.14 In contrast, AmB (a heptaene) acts both as an antifungal agent 
as well as a small molecule ion channel mimic.14 Based on these findings, we sought to 
characterize the minimum length or number of double bonds in the polyene region 
required for ion channel formation. Identification of a pentaene or hexaene polyene 
macrolide (Figure 37), would enable a systematic investigation of the impact of polyene 




Figure 37. Predicted Chemical Structures of Polyene Macrolides with Varying 
Polyene Lengths.21 Based on biosynthetic gene cluster analysis and Prediction 
Informatics for Secondary Metabolomes (PRISM), we show the following chemical 
structures for known or predicted polyene macrolides and their producing organisms A. 
Lucensomycin (tetraene), B. small molecule produced by Lentzea albida (tetraene), C. 
Eurocidin D (pentaene), D. small molecule produced by Amycolatopsis saalfeldensis 
(hexaene), E. small molecule produced by Lentzea waywayandensis (heptaene), F. 
Levorin a.k.a. Candicidin (heptaene), and G. Partricin A a.k.a. Mepartricin (heptaene). 
 
 
In addition, our preliminary results suggest that p-amino benzoic acid (PABA) 
containing polyene macrolides show at least a 10-fold reduction in concentration required 
for ion channel formation. Non-PABA containing polyene macrolides AmB and Nyst. 
restored cell growth in potassium (K+) transporter deficient yeast at 125 nM and 1 μM 
respectively. In contrast, PABA containing polyene macrolides Candicidin (Can.) and 
Mepartricin (Mep.), showed potent rescue of cell growth at 8 nM. Mechanistically, we 
predict that the PABA motif may anchor the polyene macrolide to lipid membranes to 
increase the probability of ion channel formation. To further understand this phenomenon, 
we are interested in identifying new PABA containing polyene macrolides and studying 
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their ability to bind to sterols and/or to form ion channels. We intend to characterize the 
binding interactions of these polyene macrolides to sterols through solid state nuclear 




 We first sought to identify novel polyene macrolides from producing organisms, the 
majority of which are anticipated to come from the Streptomyces genus and related 
members. We hypothesized that analysis of the biosynthetic gene clusters from these 
known natural product producers would yield closely related species that potentially 
biosynthesize previously uncharacterized polyene macrolides. To probe our hypothesis, 
we input the genomes of known polyene macrolide producing strains through RODEO 
analysis, identified strains which potentially produce uncharacterized polyene macrolides, 
and attempted to express extracts from them (Figure 38).  
 
 
Figure 38. Identification of Potential Polyene Macrolide Producing Organisms. The 
general workflow for natural product discovery includes the input of biosynthetic gene 
clusters from known polyene macrolide producing organisms into RODEO, to identify 
related and uncharacterized species. For demonstration purposes, a known producer of 
Trichomycin, S. hachijoensis is shown here. Next, through PRISM analysis, structural 
predictions can be made of the predicted, expressed small molecules. Next, candidate 
producing organisms are cultured under various media conditions to enhance the 
probability of natural product expression. Last, extracts are isolated and characterized via 
a suite of analytical and functional assays.  
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 RODEO analysis revealed four main groups (Figure 39) including producing 
organisms of Nat. like compounds, Nyst./AmB like compounds, PABA containing 




Figure 39. RODEO Analysis of Mycopolyene Biosynthetic Gene Clusters. 
Biosynthetic gene cluster analysis of known polyene macrolide producing organisms  
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Figure 39. (continued) 
revealed organisms that produce Natamycin like compounds (highlighted in purple), 
Nystatin/Amphotericin like compounds (shown in green), PABA containing compounds 
(depicted in orange), and potential uncharacterized compounds (shown in blue).21  
 
 
 With our candidate producing strains in hand, we cultured each bacterial strain 
under a suite of different media conditions including glycerol-sucrose-beef extract-
casamino acids (GuBC), International Streptomyces Project 2 (ISP2), ISP4, mannitol soy 
(MS), nutrient broth (NB), Reasoner’s 2A (R2A), and/or Staibs. We tested a variety of 
media conditions to increase the probability of small molecule expression because 
different bacterial strains have specific nutritional requirements. Next, we extracted with 
methanol (MeOH), as most polyene macrolides are soluble in this organic solvent. We 
analyzed the extracts via tetrazine labeling which specifically detects the presence of 
electron-rich alkenes in the polyene region. To check for biological activity, we applied 
our disc diffusion assay to assess for yeast cell killing, and for cell rescue via ion channel 
activity.  
 First, to determine whether each of our bacterial extracts possesses antifungal 
activity, wild-type (WT) yeast were streaked onto agar plates. We then added either 10 
μL of DMSO control or 10 μL of each bacterial extract and incubated the plates for 24 
hours. Extracts with antifungal activity showed prominent zones of cell inhibition around 




Figure 40. Representative Disc Diffusion Assay Images for Yeast Cell Killing. To 
assess for antifungal activity of these bacterial extracts, we performed disc diffusion 
assays. On agar plates coated with wild-type (WT) yeast, we placed sterile paper discs 
and then applied 10 μL of DMSO and 10 μL of each bacterial extract. After 24 hours of 
incubation, plates were examined for fungal cell killing i.e. the presence of a zone of 
inhibition. Shown are the bacterial extracts tested from strain B3253 grown under an array 
of media conditions, A. GuBC, B. ISP2, C. ISP4, D. MS, E. R2A, F. Staibs. Each bacterial 
extract showed antifungal activity compared to the DMSO control.22  
 
 
 We observed robust antifungal activity of extracts (Table 9) from AmB producer S. 
nodosus (positive control), a Eurocidin and congeners producer (ISP5604), Levorin 
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(a.k.a. Can.) and congeners producers (strains B3253, S37, B16016, and B12325), a 
Partricin (a.k.a. Mep.) producer (B1868), and uncharacterized producers (WC3896 and 
B3698).  
Table 9. Yeast Cell Killing Results from Potential Polyene Macrolide Producing 
Organisms. Extracts were isolated from the indicated bacterial strains grown under a 
suite of media conditions including GuBC, ISP2, ISP4, MS, NB, R2A, and Staibs. Extracts 
with antifungal activity after 24 hours are indicated, ND = not determined. 
 
  
We then evaluated extracts for ion channel activity. To do so, we employed our 
disc diffusion assay, but this time streaked potassium (K+) transporter deficient trk1Δtrk2Δ 
yeast that are unable to grow under standard laboratory conditions (10 mM KCl YPAD). 
Extracts containing small molecules with ion channel activity would promote restoration 
of cell growth in trk1Δtrk2Δ yeast. We observed that in contrast to the DMSO controls, 
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extracts containing potential polyene macrolides with the capacity for forming ion 
channels, promoted vigorous rescue of trk1Δtrk2Δ cell growth (Figure 41) by 24 hours.  
 
Figure 41. Representative Disc Diffusion Assay Images for Yeast Cell Rescue. To 
assess for ion channel activity of these bacterial extracts, we performed disc diffusion 
assays. Trk1Δtrk2Δ yeast were streaked onto agar plates. After, we applied sterile paper 
discs and then pipetted onto each disc either 10 μL of DMSO or 10 μL of each bacterial 
extract. After 24 hours of incubation, plates were examined for rescue of cell growth i.e. 
zone of functional complementation. Shown are the bacterial extracts tested from strain 
B3253 grown under an array of media conditions, A. GuBC, B. ISP2, C. ISP4, D. MS, E. 





 We observed ion channel activity of extracts (Table 10) from AmB producer S. 
nodosus (positive control), Can. and congeners producers (B3253, S37, B16016, 
B12325), a Mep. and congeners producer (B1868), and uncharacterized strain B3698. 
Eurocidin D (pentaene) did not promote rescue of cell growth.  
Table 10. Results of Yeast Cell Rescue Assay for Tested Extracts from Potential 
Producing Organisms. Extracts were isolated from the indicated bacterial strains, grown 
under a suite of media conditions including GuBC, ISP2, ISP4, MS, NB, R2A, and Staibs. 
The outcomes of the rescue assays after 24 hours are shown, ND = not determined. 
 
 
These findings suggest that a pentaene polyene core (e.g. as in Eurocidin) is 
insufficient in length for ion channel activity. To further determine the length of the polyene 
core necessary for ion channel activity, we are immensely interested in identifying a 
producer of a hexane polyene macrolide. Utilization of this hexane small molecule as a 
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chemical probe will show the minimum polyene length required for ion channel activity. 
Current efforts are geared towards expressing a predicted hexane polyene macrolide 
from producing organisms including A. jejuensis and A. saalfeldensis, based on RODEO 
and PRISM analyses (Table 11). Due to the lack of detectable tetrazine labeling, we 
believe that there was no expression of these natural products, from most of these strains. 
We are actively pursuing various methods to try to improve expression, including culturing 
cells under an even more extensive set of media conditions, and employing different 
expression vector systems. 
Table 11. Potential Producing Organisms of Polyene Macrolides of Varying Length. 
RODEO and PRISM analyses yielded several, uncharacterized producing organisms 
predicted to generate polyene macrolides of different lengths including a tetraene, 
pentaenes, hexaenes, heptaenes, and an octaene. Tetrazine labeling was only detected 
in the extracts from S. eurocidicus.  
 
 
 To rule out the possibility of unintentionally adding exogenous K+ in the trk1Δtrk2Δ 
rescue of cell growth assays (i.e. false positive), we quantified the total K+ content of the 
bacterial extracts. Potentially, we are observing restored cell growth in the trk1Δtrk2Δ 
yeast due to high K+ supplementation (from the extracts). We determined the total K+ 
content through performing inductively coupled plasma-mass spectrometry (ICP-MS).23 
111 
 
ICP-MS analysis (Figure 42) revealed raw K+ values under 40 parts per million (ppm). 
Taking into account the dilution factor (5 μL of sample per 245 μL of solvent), the final K+ 
content is below 2000 ppm per sample and is low. Thus, these results further support that 
trk1Δtrk2Δ rescue of cell growth is due to the ion channel activity of the extracts rather 
than direct K+ supplementation.  
 
Figure 42. ICP-MS Quantification of K+ Content in Extracts. The raw K+ content was 




 Through RODEO and PRISM analyses, we uncovered previously uncharacterized 
polyene macrolide natural products that may serve as promising novel antifungal agents 
and small molecule mimics. Members of the Can. genus (B3253, S37, B16016, B12325) 
produced natural products with both antifungal and ion channel activity. Future efforts will 
be geared towards the purification (HPLC) and in-depth structural characterization 
(ssNMR, UV-VIS, etc.) of these extracts. In addition, we are interested in determining the 
relative ion selectivities of each predicted small molecule ion channel. Do these small 
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molecule ion channels show a difference in selectivity for cations (K+, H+, and/or Na+) vs. 
anions (Cl- and/or HCO3-)? Customizing small molecule ion channels that have different 
ion selectivities, for different protein ion channel deficiencies could improve therapeutic 
outcomes, by minimizing the dosage required for effective transport of specific ions. 
Furthermore, use of more selective ion channels could also minimize unwanted side 
effects by reducing the undesired transport of other ions.  
 We found that the pentaene Eurocidin effectively kills yeast but does not promote 
ion channel formation. This key finding provides further clues into the structure activity 
relationship between polyene length and ion channel formation; wherein shorter polyene 
macrolides still bind sterols but do not promote ion channel formation. We are heavily 
interested in identifying a hexaene polyene macrolide to further probe the minimum 
polyene length required for ion channel activity. 
 Furthermore, our group is interested in understanding from an evolutionary 
perspective how the core scaffold of polyene macrolides has changed throughout time. 
We hypothesize that polyene macrolide producing organisms share a common ancestor 
that expressed a tetraene like polyene macrolide. Then through gene transfer and/or 
duplication events, the length of the polyene region increased to eventually give rise to 
heptaenes. Possibly, octaene polyene macrolides exist but to our knowledge this class of 
polyene macrolides has not been identified. Moreover, we predict that organisms 
producing PABA containing small molecules appeared later, as these more potent 
antifungal agents could provide some evolutionary benefit for survival. Potentially, 
organisms that produced PABA containing small molecules, could produce less of these 
small molecules needed for effective protection against invading yeast cells, thereby 
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enabling them to conserve energy and nutrients for other biological processes. 
Alternatively, the opposite sequence of events may have occurred wherein through loss 
of function or gene deletion events, polyene macrolides became less functionalized and 
shorter. Further study into the lineage of polyene macrolide producing organisms is 
warranted. 
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Methods and Materials 
 
Mid-Throughput Yeast Screening Assay 
This protocol was modified from The National Committee of Clinical Laboratory 
Standards document M2-A9.24 We cultivated 3-5 colonies of nonisogenic WT and 
nonisogenic trk1Δtrk2Δ cells in 50-100 mL each of 100 mM KCl YPAD pH 5.0 medium. 
At 24 hours, we harvested about 30 mL of saturated cell cultures by centrifuging at 500 
X G for 5 min, 23°C. We poured off the supernatant. Then we resuspended the cells in 
35 mL each of sterile Milli-Q H2O. Next, we vortexed the cells and recentrifuged. We 
repeated the wash step once more. This time, we removed the supernatant and 
resuspended the cells in 5 mL each of no K+ added YPAD pH 5.0 medium. We briefly 
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vortexed the cells and brought them over to the UV-VIS. Under the sterile field, we diluted 
the WT and trk1Δtrk2Δ cells to OD600 values between 0.090 to 0.110. 
Next, we streaked the trk1Δtrk2Δ cells onto no K+ added YPAD pH 5.0 agar plates 
(large pie size plates). To do so, we used sterile cotton applicators and dipped the cotton 
tip into the trk1Δtrk2Δ cell suspension. We streaked 1/4 of the plate. Then we got a new 
cotton tip and dipped it into the trk1Δtrk2Δ cell suspension and streaked the next quarter 
of the plate. We did this again for the remaining half of the plate. We rotated the plate 60° 
and repeated this process. We rotated the plate an additional 60° and repeated this step. 
We did these steps three more times, for a total of 6 rotations. Then we used the cotton 
applicator to trace the inner rim to ensure an even coating of cells. We let the trk1Δtrk2Δ 
plates settle for 15-20 minutes upright. Then we placed sterile paper discs onto each 
plate. We did the same for the WT cells. We left the plates undisturbed for 10 minutes. 
Afterwards, either 10 μL of DMSO, S. nodosus extract, purified AmB (4 mg/mL, 
Ampho99 from Gold Biotechnology), purified Nat. (4 mg/mL) controls, or 10 μL of extracts 
were pipetted onto each respective disc. The plates rested upright for 20 minutes. Then 
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